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Chapter 1 
Aberrant pancreatic expression of hedgehog ligands in 
transgenic zebrafish induces progressive fibrosis by 
recruiting and activating myofibroblasts through 
paracrine signaling 
1. Abstract 
Hedgehog (Hh) signaling is frequently up-regulated in fibrogenic pancreatic 
diseases including chronic pancreatitis and pancreatic cancer. Although recent series 
suggest exclusive paracrine activation of stromal cells by Hh ligands from epithelial 
components, debates still exist on how Hh signaling works in pathologic conditions. 
To explore how Hh signaling affects the pancreas, transgenic phenotypes of zebrafish 
over-expressing either Indian Hh or Sonic Hh were investigated. This investigation 
was done along with green fluorescence protein (GFP) to enable real-time observation, 
or GFP alone as control, at the ptf1a domain.  Transgenic embryos and zebrafish were 
serially observed for transgenic phenotypes, and investigated using quantitative reverse 
transcription-polymerase chain reaction (qRT-PCR), in situ hybridization, and 
immunohistochemistry. 
The results showed that over-expression of Ihh or Shh reveals virtually identical 
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phenotypes. Hh induced morphologic changes in the developing pancreas without 
derangement in acinar differentiation. The transgenic zebrafish showed progressive 
pancreatic fibrosis intermingled with proliferating ductular structures, which is 
accompanied by the destruction of the acinar structures. Both myofibroblasts and 
ductular were activated and proliferated by paracrine Hh signaling, showing restricted 
expression of Hh downstream components including Patched1 (Ptc1), Smoothened 
(Smo), and Gli1/2 in those Hh-responsive cells. Hh ligands also induced matrix 
metalloproteinases (MMPs), especially MMP9 in all Hh-responsive cells, and 
transform growth factor-ß1 (TGFß1) only in ductular cells. Aberrant Hh over-
expression, however, did not cause pancreatic tumors. On treatment with inhibitors, the 
embryonic phenotypes were found to be reversed by either cyclopamine or Hedgehog 
Primary Inhibitor-4 (HPI-4).  Pancreatic fibrosis was only prevented by HPI-4. 
This study provides strong evidence of Hh signaling which induces pancreatic 
fibrosis through paracrine activation of Hh-responsive cells in vivo. Induction of 
MMPs and TGFß1 by Hh signaling expands on the current understanding of how Hh 
signaling affects fibrosis and tumorigenesis. These experiments showed that the 
transgenic models can be a valuable platform in exploring the mechanism of fibrogenic 
pancreatic diseases which are induced by Hh signaling activation. 
 
Key words: Matrix metalloproteinase, transforming growth factor-ß, Hedgehog 
inhibitor, paracrine action 
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2. Introduction  
Hh ligands are secreted glycoproteins and they initiate hedgehog signaling upon 
binding to Patched (Ptc) receptors. The signaling is transmitted through Smoothened 
(Smo)’s activation, resulting in the Gli-mediated transcriptional up-regulation of Hh 
target genes. This signaling plays a critical role in both physiologic and pathologic 
conditions by participating in cell differentiation and tissue patterning during early 
embryonic development and in tissue homeostasis as well as tumorigenesis in adult 
organs [1, 2]. The Desert Hedgehog (Dhh) is known to be largely restricted by gonads 
during embryonic development [3, 4]. On the other hand, the Indian Hedgehog (Ihh) 
and Sonic Hedgehog (Shh) are expressed in various organs, including the endoderm 
and the gastrointestinal tract; thereby showing an overlapped expression, suggesting 
that they are functionally redundant [5,6]. 
The pancreas is one of the organs where Hh signaling is strictly controlled. 
Although inactivation of Hh signaling is a crucial event for proper pancreatic 
development and differentiation, this signaling is frequently reactivated in fibrogenic 
pancreatic diseases. For instance, chronic pancreatitis and pancreatic ductal 
adenocarcinoma, with several components of Hh pathway are frequently and often 
markedly up-regulated in early stages of those conditions [7-9].Thus, these are 
representative of pancreatic diseases accompanying prominent desmoplastic reaction, 
in which active Hh signaling is somehow involved in fibrogenesis. An in vitro study 
revealed enhanced migration of pancreatic stellate cells by exogenous Ihh[10]. 
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Moreover, the impact of Hh signaling on fibrosis does not seem to be confined to the 
pancreas. It also exerts an effect on fibrosis of the lungs, bile duct, and liver. This 
suggests that a similar paradigm works in various organs [11-13]. 
It has been well-documented that Hh signaling relies on paracrine action for proper 
patterning of the gastrointestinal tract during murine development [14]. Though 
evidence from recent observation has suggested a paracrine mechanism for Hh 
signaling in both physiologic and pathologic conditions [15], an autocrine mechanism 
cannot be completely excluded in certain types of malignancy [16, 17]. These findings 
reflect the possible existence of cell-type or organ-dependency, necessitating further 
clarification of Hh signaling. This raises a question regarding pathologic consequences 
of aberrantly expressed Hh ligands in the exocrine pancreas. 
Since the early 1980s, the zebrafish has been widely used for the study of genetics 
and developmental biology, and is often exploited as a disease model [18]. 
Conservation of the genetic program strengthens the power of using the zebrafish 
model in simulating human diseases. Frequently, the orthologs of the human gene are 
duplicated in zebrafish. The orthologs of Ihh and Shh are also duplicated in zebrafish, 
suggesting the existence of redundancy within subtypes. Recent advances in 
technology have facilitated the establishment of transgenic zebrafish with greater 
efficiency and convenience. The implication of Hh signaling and pancreatic fibrosis 
has been firmly documented as a result of in vitro studies [10], specimens of diseased 
pancreas [19], and xenograft model of pancreatic cancer [20]. Nonetheless the direct 
effect of an aberrant Hh expression on the pancreas has not clearly established. In an 
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earlier study [21], the authors demonstrated that precancerous lesions developed in the 
pancreas of Pdx1-Shh transgenic mice. However, they did not mention any findings 
which are relevant to pancreatic fibrosis. Therefore, the present study was designed to 
investigate the effects of Hh ligands in the exocrine pancreas of transgenic zebrafish in 
which Ihha or Shha is over-expressed in the ptf1a domain. The results show in vivo 
evidence that Hh ligands cause pancreatic fibrosis by paracrine activation of 
myofibroblasts, as well as ductular cells. 
 
3. Materials and Methods  
1. Ethics Statement 
It was not necessary to obtain approval by the Laboratory Animal Committee at 
Yonsei University College of Medicine. The current committee does not request 
approval when non-mammalian models are used for experiments. This study, however, 
was strictly carried out to minimize suffering. All live images of embryos were taken 
under anesthesia using E3 media with 0.3mg/mL tricaine. All adult zebrafish to be 
processed for experiments were euthanized by immersion in an ice-water bath. 
 
2. Transgenesis 
Transgenic constructs were generated by modifying JD21-UAS: GFP-Kras, a kind 
gift from Steven D. Leach, which allows Tol2- to mediate transgenesis and is designed 
to co-express the transgene along with green fluorescence protein (GFP)  which  
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enabled real-time observation (Fig. 2A).The cDNA for zebrafish Ihha (GenBank 
accession No. BC133983.1) was purchased from Openbiosystem Co., and zebrafish 
Shha (GenBank accession No. BC162395) was cloned using cDNA generated from 
three day-old wild-type embryos (AB line, ZIRC ZL1).While using polymerase with 
the proofreading function (Invitrogen), the GFP sequence including a polyA site was 
PCR amplified from pEGFP1 vector (Clontech) using F-GFP-Nco1/R-GFPpA-Xho1 
primers. It was then digested and inserted into Nco1/Xho1 sites of JD21-UAS:GFP-
Kras to generate JD21-UAS:GFPpA-Kras. Ihha and Shha were amplified with PCR 
usingF-Ihha-Mlu1/R-Ihha-Cla1 and F-Shha-Mlu1/R-Shha-Cla1 primers, respectively, 
then inserted into Mlu1/Cla1 sites of JD21-UAS: GFP-Kras, separately to generate 
JD21-UAS:Ihha and JD21-UAS:Shha. Each UAS: Ihha and UAS: Shha sequence was 
PCR amplified using F-UAS-Xho1/R-Ihha-Cla1 and F-UAS-Xho1/R-Shha-Cla1, 
respectively. It was then inserted into Xho1/Cla1 sites of JD21-UAS-GFPpAKras, 
separately, to generate the final transgene constructs JD21-UAS: GFP-UAS: Ihha and 
JD21-UAS:GFP-UAS:Shha.Schematic illustration for the generation of transgene 
construction is shown in Figure 1. The control construct was generated by digesting 
JD21-UAS-GFPpA-Kras with Xhol1/Cla1, blunting, and then self-ligation. . JD21-Ins-
DsRed was generated for targeted expression of biomarker in pancreatic beta cells. 
Upstream a 1kb sequence of the preproinsulin gene was PCR amplified from genomic 
DNA using F-Ins1kb-Apa1/R-Ins1kb-Nco1 primers and inserted into Apa1/Nco1 sites 
of JD21-UAS-GFPpA.Then, DsRed was PCR amplified from pDsRed-monomer-N1 
(PT3795-5, Invitrogen Co.) using F-DsR-Nco1/R-DsR-Cla1 and inserted into 
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Nco1/Cla1 site of JD21-Ins-GFPpA. All constructs were sequenced and verified using 
appropriate primers. Primers used for transgene constructs are listed in Table 1. 
Each injection mixture was made by reconstituting Tol2-transposase mRNA (20 
ng/ul) and a transgene construct (20 ng/ul) in Danieu’s buffer mixed with 0.03% 
phenol red. Single-cell stage Tg(Ptf1a:Gal4) embryos were transferred to a molded 
agarose dish and 4pL of injection mixture was introduced by yolk injection using a 
MMPI-2 micro injector. Approximately 50% of injected embryos survived. On day 
two, embryos showing GFP at the Ptf1a domain were selected using a fluorescence 
microscope, raised until adulthood, and out-crossed to generate F1 transgenic zebrafish. 
The utilization of Tol2-mediated transgenesis greatly enhanced the transgenic 
efficiency that 25-50% of F0 zebrafish from each construct gave rise to F1 offspring 
expressing transgenes. In each clutch of F1 embryos, approximately 10% showed 
transgene expression. Among the F1 progenies, embryos showing faithful expression 
were selected and raised to produce F2 progenies. All transgenes were transmitted into 
normal Mendelian ratios. Transgenic zebrafish were raised in a standardized aquaria 
system (Genomic-Design, Daejeon, Korea) according to standard protocols. Embryos 
to be processed for whole mount examination of GFP expression or ISH analyses were 
placed in 0.003% phenylthiourea at 24 hours post-fertilization (hpf) to inhibit 
pigmentation. 
 
3. Histology and Immunohistochemistry (IHC) 
Histologic evaluation was performed in a subset of F2 transgenic zebrafish at 
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1,3,6,9, and 12-month(s). Hematoxylin and eosin (H&E) staining and IHC were 
performed according to the standard protocols. Primary antibodies used for 
immunohistochemistry were rabbit anti-α-smooth muscle actin (α-SMA) (Abcam 
ab15734, 1:500), rabbit anti-Smoothened (Smo) (Abcam ab72130, 1:200), rabbit anti-
Gli1 (Upstate AB3444, 1:500), rabbit anti-Gli2 (Abcam ab26056, 1:300), mouse anti-
Transforming growth factor ß1 (TGFß1) (R&D MAB1835, 1:500), rabbit anti-matrix 
metalloproteinase 9 (MMP9) (Abcam ab38898, 1:500), mouse anti-cytokeratin (CK) 
AE1/AE3 (Abcam ab961, 1:500), mouse anti-proliferating cell nuclear antigen (PCNA) 
(Abcam ab29, 1:1000), and rabbit anti-phosphohistone H3 (pHH3) (Cell Signaling 
9701, 1:200). Horse radish peroxidase (HRP)-conjugated secondary antibodies were 
utilized and colored using DAB solution. Slides were counterstained with hematoxylin, 
dehydrated, and mounted with Histomount (Zymed Co.). 
4. Western blotting 
A western blot hybridization was performed as previously described [22], using the 
exocrine pancreas dissected under a fluorescence microscope from 4 month-old 
zebrafish. The zebrafish pancreas does not form a single solid organ, but exists as 
thread-like structures being dispersed between visceral organs and embedded in fatty 
tissues. For each group, samples were collected from 20 to 30zebrafish and processed 
for protein extraction. Proteins were resolved by 10% SDSP-gels, blotted onto a 
nitrocellulose membrane, stained for 5 minutes with Ponceau S, blocked for 1 h in 5% 
milk in PBST, incubated over night at 4°C with a primary antibody in blocking buffer, 
 10 
 
washed 4 times with PBST, and incubated for 1h with horseradish peroxidase-
conjugated secondary antibody. Labeled proteins were detected by ECL reagents and 
Hyperfilm ECL (Amersham Biosciences).  
5. In situ hybridization (ISH)  
ISH was performed either using 4% paraformaldehyde-fixed whole embryos or on 
4-um sections of 4% paraformaldehyde-fixed, paraffin-embedded tissues as described 
previously [23]. To generate riboprobes, the corresponding coding sequences were 
PCR amplified from cDNA, TA cloned into pCRII vector (Invitrogen, CA, USA), and 
sequence-verified. Then, digoxigenin-labelled riboprobes were generated with the IVT 
kit (Roche Applied Science, Germany) using SP6 or T7 RNA polymerase depending 
on the orientation of the inserts. Primers used for TA cloning are listed inTable 3. 
Hybridized embryos or sections were bound with alkaline phosphatase-conjugated 
anti-Dig antibody, and colored using NBT/BCIP solution. Sections were 
counterstained with neutral red and mounted with Histomount. 
6. Whole mount immonofluorescence 
Whole mount immunofluorescence was ISH was performed using 4% 
paraformaldehyde-fixed whole embryos essentially as described previously 
[23].Embryos were incubated overnight in10% goat serum with rabbit anti-CPA 
(Rockland, 100-4152), washed 3 times with PBST, and then incubated overnight in 10% 
goat serum with Cy3-conjugated anti-rabbit antibody (Jackson Labs). To identify 
individual acinar cells, photographs were obtained by using a Zeiss 700 confocal 
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microscope with a 10X eye lens and a 20X objective lens.   
7. Imaging 
Photographs were obtained using an Olympus BX51 for slide sections and an 
Olympus MVX10 for whole mount embryos. If not indicated, all section images were 
taken with a 10X eye lens and a 40X objective lens. If needed, zoom functions were 
used to obtain further magnified images. 
8. Semi-quantitative and quantitative reverse transcription-PCR (RT-PCR) 
RT-PCR was performed using the exocrine pancreas dissected under a fluorescence 
microscope from three-month old zebrafish. For each group, samples were collected 
from five to six zebrafish and processed for RNA extraction. Real-time, quantitative 
RT-PCR was performed as previously described [18], using 7300 Real Time PCR 
System (Applied Biosystems, Foster city, CA) with the QuantiTectTMSYBRGreen 
PCR Kit (Qiagen, Valencia, CA). Samples were in triplicate, and all experiments were 
repeated three time using separately prepared samples. Statistical analysis was 
performed using SPSS 11 software. Statistical significance for quantitative RT-PCR 
was analyzed by the Mann-Whitney U test. Primer sequences are shown in Table 2. 
9. Treatment with Hedgehog inhibitors 
To antagonize Hh signaling, either cyclopamine (Sigma-Aldrich Co., C4116) or Hh 
Primary Inhibitor-4 (HPI-4) (Sigma-Aldrich Co., H4541) was used [32]. For short-term 
phenotypic reversal, Tg(Ptf1a-Gal4/UAS:GFP-UAS:Ihha) embryos were treated in a 
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petri dish from 32 hpf when Ptf1a expression first appeared in the primordial exocrine 
pancreas for five days with the maximal tolerable doses (MTDs) that would not impair 
embryonic development. MTDs were measured by treating embryos with a serial 
escalation of doses from 100 nM, which were 1uM for HPI-4 and 15uM for 
cyclopamine. Next, 12 day-old Tg(Ptf1a-Gal4/UAS:GFP-UAS:Ihha) larvae were 
treated in a 1L-breeding cage with Hh inhibitors for an extended period of up to six 
weeks. The MTDs (lethal in less than 25%) were measured again revealing 5uM for 
HPI-4 and 500 nM for cyclopamine. Cage water was daily refreshed and inhibitors 
were newly added. At week six, juvenile zebrafish were processed for histologic 
evaluation. 
 
4. Results 
1. Targeted expression of transgenes and short-term phenotypes 
In order to express transgenes from a zebrafish pancreas, Tg (Ptf1a:Gal4) zebrafish 
[24] had previously been established by bacterial artificial chromosome (BAC) and 
allowed binary expression by Gal4-UAS system. Transgene constructs were generated 
to co-express either Ihha or Shha along with green fluorescence protein (GFP) which 
enabled real-time observation (Fig. 2A). From each construct, 7 independent transgenic 
lines were successfully established: Tg(Ptf1a-Gal4/UAS:GFP-UAS:Ihha), Tg(Ptf1a-
Gal4/UAS:GFP-UAS:Shha), and Tg(Ptf1a-Gal4/UAS:GFP). The transgene expression 
levels estimated by GFP, however, varied among the F1 progenies depending on their 
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parental zebrafish. All independent lines were separately maintained. 
 
 
Figure 1. Schematic illustration for the generation of transgene constructs.  
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 Table 1 . Primers used for the generation of transgene constructs. 
Primers Sequence 
F-GFP-Nco1 5’-ATACCATGGTGAGCAAGGGCGAGGAG-3’ 
R-GFP-Xho1 5’-ATACTCGAGATACATTGATGAGTTTGGAC-3’ 
F-Ihha-Mlu1 5’-ATAACGCGTGCCACCATGCGTCTCCCCGTGGTGTT-3’ 
R-Ihha-Cla1 5’-ACTAATCGATTCATCTATCATTGTCCATCA-3’ 
F-Shha-Mlu1 5’-ATAACGCGTGCCACCATGCGGCTTTTGACGAGAGT-3’ 
R-Shha-Cla1 5’-ACTAATCGATTCAGCTTGAGTTTACTGACA-3’ 
F-Ins1kb-Apa1 
5’-ACTAGGGCCCATTTAACTTCAGCCCACAGTCT-3’ 
R-Ins1kb-Nco1 
5’-CACACTGCCATGGTCACACT-3’ 
F-DsR-Nco1 
5’-ATACCATGGATGGACAACACCGAGGACGTC-3’ 
R-DsR-Cla1 
5’-ACTAATCGATCTACTGGGAGCCGGAGTGGCGGG-3’ 
F-UAS-Xho1 5’-ATACTCGAGCTCTGCTAACCATGTTCATG-3’ 
F-UAS-Seq 5’-TCAGCCTCACTTTGAGCTCC-3’ 
 
F-UAS-Seq was used for sequence verification of constructs. Underlined GCCACC sequence 
was inserted to satisfy Kozak sequence for proper transcription. Underlines, restriction enzyme 
sequences. 
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Figure 2. Short-term phenotypes. (A) Transgenesis strategy. (B, C) Inverted 
fluorescence and transgene ISH images show mosaic pattern of transgene expression in 
Hh ligand-expressing embryos. (D) Whole mount ISH for ptf1a at 48 and 96hpf. Inlet 
figures are dorsal views with anterior to the top. A, anterior. Hh over-expression did 
not impair migration of ptf1a-expressing exocrine progenitor cells, showing ptf1a 
positive exocrine cells surrounding principal islet at 48 hpf. (E) Whole mount ISH for 
Foxa3 and Gata6, endodermal markers during development. Dorsal views with anterior 
to the top. The FoxA3 and Gata6 are properly expressed in the liver, intestine, and 
exocrine pancreas, and the endodermal morphologies are not affected by Hh over-
expression. L, Liver; I, Intestine; P, Exocrine pancreas. 
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When transgene expression was evaluated by GFP expression or by ISH, it was found 
to be spatiotemporally restricted to the Ptf1a domain (Fig. 2B, C). In control embryos, 
GFP was expressed throughout the whole exocrine pancreas. In Hh ligand-expressing 
embryos, patterns of transgene expression were not homogeneous throughout the 
whole exocrine pancreas, but rather, were mosaic for GFP and Hh ligands expression 
somewhat due to an unknown cause. Acinar cells surrounding the principal islet tended 
to show more robust expression of the transgenes. In developing zebrafish, the ptf1a-
positive cells first appear at the left side of the endoderm, migrate across the midline, 
and eventually encircle the principal islet at 48 hpf. The migration of the exocrine 
progenitor cells was not affected by Hh expression, showing the doughnut-shaped ptf1-
expressing exocrine pancreas at 48 hpf (Fig. 2D, 3A). Next, in order to visualize the 
developing endoderm, ISH was performed for endodermal markers, FoxA3 and Gata6 
at 48 and 60 hpf, respectively [25, 26].These transcriptional factors were properly 
induced in the liver, intestine, and exocrine pancreas. Also, endodermal morphologies 
were not deranged by Hh over-expression (Fig. 2E).  
The endocrine or exocrine differentiation was not compromised by Hh over-
expression (Fig. 3). To visualize the endocrine pancreas, each line was crossed with 
Ins-DsRed transgenic zebrafish. The emergence of RFP-positive endocrince cells was 
not different from that of control (Fig. 3A). The anterior endocrine cells appear as a 
small dot like structure at the rostral side of the principal islet and are visible in 
approximately 50% of the control embryos, which was also not affected by Hh over-
expression (Fig 3A). The exocrine differentiation was evaluated by trypsin, elastase, 
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and carboxypeptidase A (CPA) expression. The appearance of trypsin expression at 48 
hpf did not temporally differ from that of the control embryos. The expression of other 
exocrine markers, such as elastase and CPA were also properly induced (Fig. 3B, C). 
Aberrant Hh expression, however, caused morphologic changes of exocrine pancreas 
when estimated by GFP expression or by ISH. The exocrine pancreas in Hh-expressing 
embryos showed a short, slender, and tortuous posteriorly-growing pancreas with a 
relatively prominent head compared to that of the control, which was evident at 4 and 5 
dpf and exaggerated at 12 dpf (Fig. 3B, C). Confocal imaging of CPA 
immunofluorescence staining revealed proper exocrine differentiation of individual 
acinar cells regardless of transgene expression, suggesting that the exocrine 
differentiation program was not affected by Hh over-expression. 
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Figure 3. Unaffected endocrine and exocrine differentiation by Hh over-
expression. (A) Fluorescence images showing the endocrine (RFP) and exocrine 
pancreas (GFP). When each transgenic fish is crossed with Ins-DsRed zebrafish, the 
development of insulin-expressing endocrine pancreas is not impaired by Hh over-
expression. A smaller dot-like insulin-positive structure (white arrowheads) which 
corresponds to the anterior endocrine cells is observed in approximately half of the 
control and Hh-expressing embryos. (B, C) Whole mount ISH for trypsin, elastase, and 
carboxypeptidase A (CPA) at different time points. Over-expression of Hh ligands does 
not compromise the exocrine differentiation of the zebrafish pancreas, as evidenced by 
the proper and timely expression of trypsin. Expression of the other exocrine markers 
is also unaffected by Hh over-expression. Hh over-expression, however, induces subtle 
morphologic changes of the exocrine pancreas, showing a short, slender, and tortuous 
posterior pancreas compared to those of controls, which is evident by ISH for exocrine 
markers at 4 and 5 dpf and exaggerated at 12 dpf. (D) Confocal images of 
immunofluorescence staining for CPA. Regardless of transgene (GFP) expression, 
most acinar cells express CPA, suggesting unaffected exocrine differentiation by Hh 
over-expression. Lat., lateral. 
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2. Aberrant Hedgehog ligands cause pancreatic fibrosis 
All Hh-expressing zebrafish from independent lines revealed a varying degree of 
pancreatic fibrosis and the desmoplasia was accumulated as the zebrafish aged (Fig.4). 
Among the 3 groups of independent lines from each construct, single representative 
line per group which revealed consistent and robust expression of transgenes was 
selected. Both Ihh and Shh induced pancreatic fibrosis undistinguishable by histology 
alone. It is notable that Shh induced phenotypically more severe pancreatic fibrosis 
than Ihh at the given time points. The pancreatic fibrosis was progressive and 
manifested at as early as the age of one month (Fig.4A). Fibrotic bands segregated and 
compartmentalized the exocrine glands, which resulted in the marked destruction of 
acinar structures at three months (Fig.4B). Though typical lesions with fibrosis did not 
involve infiltration of inflammatory cells, transgenic zebrafish occasionally revealed 
inflammatory lesions similar to acute pancreatitis in humans, demonstrating infiltration 
of inflammatory cells, fluid collection, and necrosis (Fig.4C,D). These findings, 
however, were unusual and appeared in less than 10% of the Hh-expressing zebrafish 
pancreas; therefore, it appeared to be caused by ductal obstruction resulting from 
fibrosis. 
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Figure 4. Histopathologic findings showing progressive pancreatic fibrosis. (A) 
Progressive pancreatic fibrosis starts at as early as 1-month old in Hh-expressing 
transgenic zebrafish. In non-fibrotic area, Individual morphology of the pancreatic 
acini and acinar cells is not unusual. (B) A principal islet is seen in control, which is 
well-circumscribed by acinar cells (black arrowheads). In Hh-secreting lines, 
accumulation of fibrosis results in the destruction of the morphologic architecture, 
which is prominent even at 3 months. Fibrotic bands are contiguous from the bowel 
wall forming adhesion between the bowel and the pancreas (red arrows), suggesting 
recruitment of myofibroblasts from the muscle layer of the bowel. Along with fibrosis, 
an increasing number of ductular structure appears within fibrotic area at 3 months of 
age (black arrows). (C, D) The pancreas at 6-months old. (D) An enlarged view of the 
red box in (C). Contrary to the islet of control in B, some islets of the Hh-expressing 
pancreas are completely encircled by fibrosis (red arrowheads), which is typical 
finding in chronic pancreatitis of human. The number of ductular structure further 
increased (black arrows). Occasionally, acute pancreatitis-like changes are noted, 
showing the infiltration of inflammatory cells and cystic space filled with mucinous 
material (asterisks). (E) The exocrine pancreas of 9 month-old zebrafish shows more 
accumulation of fibrosis and ductular structures (black arrows). At center image, a 
large pancreatic duct (asterisk) is seen, being surrounded by fibrosis and ductular 
structures. If not specified, microscopic images are 400X.Bars, 50 μm. 
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The fibrotic changes were typically observed in the pancreas between the liver and 
gut, where the exocrine pancreas surrounded the principal islet. Interestingly, this 
corresponded to the area where the transgene expression was most robust. A prominent 
fibrotic area revealed a discernable whitish plaque in the entire dissected viscera and 
corresponded with the spot showing strong GFP expression (Fig. 5A). On ISH for Hh 
molecules which are co-expressed with GFP, transgene expression was strictly 
restricted to pancreatic acinar cells (Fig.5B) which express a transcription factor Ptf1a 
over a lifetime. In the non-fibrotic area, however, the acinar and cellular morphology 
were well-preserved, suggesting acinar destruction was secondary to the accumulation 
of fibrotic change. 
Proliferating myofibroblasts were invariably positive for α-SMA (Fig. 5D). The 
majority of the activated myofibroblasts seemed to come from the gut wall as the 
fibrotic strands were outstretching from the gut wall, forming an adhesion between the 
bowel and pancreas (Fig.4B). α-SMA’s reactivity was also noted in the muscle layer of 
the gut and pancreatic duct in control. Fibrotic bands found to be positive for α-SMA 
stain, also formed a contiguous strand from the gut wall (Fig.5D), suggesting 
recruitment and activation of myofibroblasts from the muscle layers of the gut. 
Myofibroblasts in the pancreatic ductal wall were also activated and proliferated as the 
muscle layers thickened and expressed α-SMA (Fig.5D). Occasionally, α-SMA-
reactive cells were observed within the control pancreas, suggesting the presence of 
putative pancreatic stellate cells in the zebrafish pancreas (Fig.5D). The source of 
proliferating myofibroblasts along with the preferential change in fibrosis around the 
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principal islet suggested that Ihha or Shha recruited and activated any myofibroblasts 
in the vicinity of the pancreas where secreted Hh ligands could reach and mediate any 
effect.  
Interestingly, proliferation of ductular structures was also noted at the age of three 
months, showing dense fibrotic bands intermingled with ductules (Fig.4B). Along with 
the progression of fibrosis, the ductular structures had also accumulated within the 
fibrotic area. To see whether these ductular structures were formed by proliferation or 
by mere entrapment of existing ductules, IHC for PCNA and pHH3 was performed. 
The majority of ductular cells were strong-reactive to PCNA and many of them also 
expressed pHH3 (Fig.5E, F), suggesting that the ductular structures were formed by 
enhanced proliferation. 
The Hh signaling has been considered as a mediator of gastrointestinal 
tumorigenesis for many years, and Pdx1-Shh mice have shown metaplastic change and 
PanIn-like lesions [21]. However, the abnormal over-expression of Hh molecules did 
not cause pancreatic tumors in this study. . Those Hh-expressing transgenic zebrafish 
were further investigated for more than a year without finding any evidence of tumor 
foci or precancerous lesions. 
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Figure 5. Hh-induced pancreatic fibrosis and proliferation of myofibroblasts. (A) 
Dissected whole viscera from 4 month-old zebrafish showing transgene (GFP) 
expression. Ventral views. Left, anterior. The pancreas of control appears as a thread-
like structure between the bowel and visceral organs (arrow). In Hh ligand-expressing 
pancreas, prominent fibrosis around the principal islets forms whitish plaque-like 
lesions showing robust GFP expression (arrowheads). Inlets are merged in bright and 
fluorescence images. (B) ISH for transgene expression. The control pancreas reveals 
negligible expression of either Ihha or Shha. In the Hh-expressing pancreas, transgene 
expression is strictly restricted to acinar cells with nil expression at myofibroblasts or 
ductular cells. (C) Trichrome stains showing fibrotic bands. (D) IHC for α-SMA. 
Muscle layers of the bowel and large pancreatic ductal wall are reactive to α-SMA in 
control (black arrows). Infreqeuently, α-SMA-positive cells are noted (black 
arrowhead) in the parenchyme of control pancreas suggesting presence of stellate cells. 
Infilitrating myofibroblasts are invariably reactive to α-SMA while proliferating 
ductular cell are not (red arrowheads). Note the thickened and α-SMA-reactive 
intrapancreatic duct wall (red arrow). Left inlets (200X) are ISH images. Right inlet is 
an enlarged view of the box. (E, F) IHC for PCNA and pHH3. Within the fibrotic area, 
both ductular cells (red arrowheads) and myofibroblasts (black arrowheads) are 
frequently reactive to both PCNA and pHH3, suggesting enhanced proliferation. 
Intestinal crypt cells are also frequently reactive to both PCNA and pHH3 (black 
arrows) and used as internal control. If not specified, microscopic images are 400X. 
Bars, 50 μm. 
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3. Differential genes involved in Hedgehog signaling and fibrosis  
In order to identify differentially expressed genes, GFP-expressing pancreases were 
dissected under a fluorescence microscope and pancreas samples were extracted from 
4-5 of each transgenic zebrafish, which were processed for RT-PCR. Among the Hh 
components, real-time RT-PCR revealed up-regulation in most of the downstream 
components including Ptc1, Smo, Gli1, and Gli2a as well as transgenes compared to 
the control, which suggested the presence of cells with active Hh signaling (Fig. 6A,B). 
The signaling pathways relevant to fibrosis comprise a long list of genes and gene 
families. An exemplary list of genes that might have been modulated by aberrant 
expression of Hh ligands was seleted. Among the tested genes, RT-PCR revealed 
marked up-regulation of TGFß1aand MMP9, and mild to modest up-regulation of 
others, including membrane type 1 matrix metalloproteinase b (MT1MMPb), MMP2, 
interleukin1b (IL1b), TGFß2, and platelet derived growth factor Aa (PDGFAa) (Fig. 
6A,B). A western blot hybridization was carried out using pooled samples from 4 
month-old zebrafish with antibodies reactive to zebrafish antigen, which also 
recapitulated RT-PCR findings (Fig. 6C). 
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Figure 6. RT-PCR and Western blot. Pancreas from 3-4 month-old zebrafish was 
dissected under a fluorescence microscope. C, Tg(Ptf1a-Gal4/UAS:GFP); I, Tg(Ptf1a-
Gal4/UAS:GFP-UAS:Ihha); S, Tg(Ptf1a-Gal4/UAS:GFP-UAS:Ihha). (A) Real-time 
RT-PCR showing differential expression of the components of the Hh pathway and 
fibrosis by Hh over-expression. Note the prominent up-regulation of MMP9 and 
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TGFß1a. (B) Electrophoretic images of RT-PCR products recapitulate real-time PCR 
data. (C) A western blot hybridization using available antibodies which are reactive to 
zebrafish antigens also recapitulates RT-PCR findings. α-SMA, 42 kD; Smo, 85 kD; 
MMP9, 75 kD; TGFß, 45 kD; ß-actin, 45 kD. * P<0.05 versus control. 
 
 Table 2.  Primers used for RT-PCR. 
Genes Sense (5’-3’) Antisense (5’-3’) 
Product 
length (bp) 
GAPDH 
AAAGTCACCGCCATC
AACGAC 
CCTTAACCTCACCCTTG
TACTT 
173 
Ihha 
ATGCGTCTCCCCGTGG
TGTT 
TGGCTCCCAGTGTCTTC
TCG 
175 
Shha 
GCTTTTGACGAGAGTG
CTGCT 
TAAGGTCTTCTCCGCGA
CAT 
163 
α-SMA 
GTGTGACGACGAAGA
AAGCA 
TTCTGCCCCATTCCTAC
CAT 
153 
Desmin 
ACGAAATATTCAGCCT
CCGC 
GAGCTCTTGGTCACCTC
GTA 
152 
Trypsin 
GAAGGCTTTCATTCTT
CTGGCTCTTT 
GGTTGCTGATCAGAGA
GCCA 
171 
Gli1 
ATGCCAGTGGATATGC
AGCC 
GGCCATGGAGGGATTA
TACA 
183 
Gli2a 
ATGGAGACCACAAGT
CCCAC 
CTTCCTTCATGATGCCG
CAT 
179 
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Ptc1 
ATGGCCTCGGATCCCA
GAGA 
CCCACAGCTTTCCCCTT
AGA 
167 
Smo 
CAAGCGCCCCTGCTCC
ATTGTT 
TGCGTGTACGGCAAAG
GCGA 
186 
MMP2 
GTTGAAGGACACGCT
GAAGAAA 
GGGTGTGCCCTAAGATT
CTG 
191 
MMP9 
ATGAGACTTGGAGTCC
TGGC 
TTAGCATTGGAGATGAC
CGC 
209 
MT1MM
Pa 
ATGTTACCGAAACTGC
AGACG 
GATTTAGGAGAGCGAA
TCGC 
173 
MT1MM
Pb 
ATGATCTGGAGCGGG
TTTAC 
CAGGCCGTAGAATCTCT
GCA 
201 
TIMP2 
TGAAGAGCGTCAGGA
GCTGTA 
GCTTGATCGGGTTCCCA
TAA 
197 
IL1b 
CATGCGGGCAATATG
AAGTC 
CATTTTGTGCTGCGAAG
TCC 
170 
TGFß1a 
GTTGGTTTGCTTGGTG
CTGA 
ATCTTCTGTCCGTCGTC
GTC 
186 
TGFß2 
TGAACTTGTACGTCTT
GAGCC 
GATCTCAGGAGGACTG
CTCA 
167 
TGFß3 
AAAGGACTGCTGTTTG
TTCTG 
ATCCCTGGTGCTGTTGT
AGA 
216 
PDGFAa 
CGCTGATCCACTTTCT
CGTC 
CGTCCTCCAGCACTTCA
TTC 
171 
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PDGFAb 
ATGAGAACCTTATTCT
GCTGC 
ATGGTGCTTCTGCTTGA
CCT 
207 
PDGFB 
GGACCCTCTTCCTCCA
TCTCT 
GGCTTCTGGGAAGACGT
TTG 
164 
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4. Paracrine activation of responsive cells by Hedgehog ligands 
Histologic expression of the Hh signaling components was assessed by either IHC 
or ISH, depending on the availability of an antibody that was cross-reactive to 
zebrafish antigen. Though Ptc1 theoretically counteracts the activation of Smo, the Hh 
ligand needs Ptc1 receptor to bind and initiate Hh signaling [27]. Ptc1 expression was 
restricted to proliferating myofibroblasts and ductular cells (Fig. 7A). The expression 
of Smo assessed by IHC was virtually identical to the Ptc1 expression (Fig. 7B). In 
control zebrafish, muscle layers of the bowel and pancreatic ducts also expressed both 
Ptc1 and Smo (Fig.7A, B), suggesting paracrine activation of these Ptc1/Smo-positive 
cells by secreted Hh molecules. Similarly to α-SMA, Smo-reactive cells were 
occasionally noted within the control pancreas (Fig.7B), which seemed to be the 
counterparts of pancreatic stellate cells. To further verify Hh signaling activation in 
responsive cells, the expression of Gli genes, the final mediator of Hh signaling by 
ISH, was evaluated. The expression of both Gli1 and Gli2a was again strictly restricted 
to myofibroblasts and ductular cells (Fig. 7C, D). Even though, there exists a non-
canonical pathway leading to the Gli1 expression [28], the Gli2 expression represents 
actual activation of the canonical Hh pathway [29, 30]. None of the acinar cells were 
reactive to Gli1 or Gli2a. The expression of Hh components in both myofibroblasts and 
ductular cells suggest that these two cellular compartments are responsive to Hh 
ligands secreted from acinar cells, activated, and proliferated to form dense fibrotic 
area intermingled with ductular structures. 
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Figure 7. Expression of the downstream components of Hh signaling at 6 month-
old zebrafish pancreas. (A) ISH for Ptc1. In control Ptc1 is expressed in the muscle 
layer of bowel and pancreatic duct. In the Hh-expressing pancreas, both proliferating 
myofibroblasts and ductular cells express Ptc1. (B) IHC for Smo reveals strong 
expression in a wide area of fibrosis. Both myofibroblasts and ductular cells are 
reactive to Smo. Likely to α-SMA immunostaining, Smo-reactive cells (red arrow) are 
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occasionally noted in the parenchyma of the control pancreas. Inlets are 200X images. 
(C, D) ISH for Gli1 and Gli2a. Whereas, the control pancreas reveals a negligible 
degree of Gli1 and Gli2a expression, activated myofibroblasts and ductular cells 
express Gli1 and Gli2a. (B-D)Black arrowheads, myofibroblasts; Red arrowheads, 
ductular cells. If not specified, microscopic images are 400X. Bars, 50 μm. 
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5. Hedgehog ligands induce MMPs and TGFß1 in Hedgehog-responsive 
cells 
MMPs function in the regulation of the extracellular matrix (ECM) organization by 
degrading ECM gives way to cellular migration. Thus, induction of MMPs is necessary 
for the progression of fibrosis. RT-PCR showed that induction of MMP9 was the most 
striking among the MMP genes evaluated in this study. While MMP2 was modest, 
MT1MMPs were mildly elevated. An immunostaining analysis revealed that both Hh-
responsive myofibroblasts and ductular cells strongly expressed MMP9 with nil 
expression in acinar cells, which suggests that activated Hh signaling was responsible 
for induction of MMP9 (Fig. 8A). 
TGFß family members also play important roles in fibrosis as well as 
tumorigenesis. Crosstalk between Hh and TGFß signaling has been found, and both 
genes are often co-expressed in epithelial compartments [13, 31]. Contrary to the 
MMP9, TGFß1 expression was strictly restricted only to proliferating ductular cells 
which were also reactive to the pan-cytokeratin antibody (Fig. 8B). This finding gives 
an important clue as to how active Hh signaling is involved in pancreatic 
tumorigenesis. Although, TGFß1 induction might have contributed to the aggravation 
of desmoplasia, it was not primarily responsible for fibrosis because ductular 
proliferation was not prominent until three months, when pancreatic fibrosis was 
already found. Unlike MMP9 and TGFß1, the expression of PDGFAa and IL1b was 
restricted to myofibroblasts (Fig.8C, D). 
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Figure 8. Expression of genes involved in fibrosis at 6 months. (A) IHC and ISH 
(inlets) showing MMP9 expression in proliferating myofibroblasts and ductular cells. 
(B) IHC for TGFß1. Contrary to MMP9, TGFß1 is expressed only in proliferating 
ductular cells which are also positive for cytokeratin. (C, D) ISH for PDGFAa and 
IL1b. Transcripts of both genes are detected in a small subset of proliferating 
myofibroblasts and ductular cells. (A-C, red arrowheads, ductular cells). Microscopic 
images are 400X. Bars, 50 μm. 
 
 
 
 
 
 
 39 
 
 Table 3.  Primers used for TA cloning to generate riboprobes 
Genes Sense (5’-3’) Antisense (5’-3’) 
Product 
length (bp) 
Trypsin 
ATGAAGGCTTTCATTCTT
CTG 
TCATGGTGTTTCTGATCC
AG 
730 
Elastase 
ATGTTCGCCCTCATCCTA
GC 
TTAGTTGTTCATCATGAC
CT 
813 
CPA5a 
ATGAAGAGGCTGCTGGT
GCT 
TTAATAAGGGTTATTCTT
GG 
1260 
Ptf1a 
ATGGACACTGTGTTGGAT
CC 
TTAGGAAATGAAATTAA
AGGG 
798 
GATA6 
ATGTATCAGACCCTGGCC
A 
CCCACCAGTGTTGAAGA
GT 
1007 
FoxA3 
ATGTTGAGCTCCGTGAAG
AT 
CGACTTGAGGTCCATCTT
CT 
1176 
Ihha 
ATGCGTCTCCCCGTGGTG
TT 
TCATCTATCATTGTCCAT
CA 
1242 
Shha 
ATGCGGCTTTTGACGAGA
GT 
TCAGCTTGAGTTTACTGA
CA 
1257 
αSMA 
GTGTGACGACGAAGAAA
GCA 
CTTCATCATACTCCTGCT 1099 
Gli1 
AGTTCGTTTGCCACTGGA
AG 
ACGTTGCTCAAGCTGTTA
AA 
1492 
 40 
 
Gli2a 
GTTTCCCGAGTCCCAGAC
TG 
CCAACTCCAGCAGAAGT
ACC 
1447 
Ptc1 
TGAAGCCTGAAACTAAG
ACTGT 
TCAGGAGAAGGACTTTG
CAA 
1363 
MMP9 
CTGCTCCATTGTTGGAAG
CT 
TTCTTTCCCACTCAGCTT
GA 
1367 
IL1b 
CATGCGGGCAATATGAA
GTC 
CTAGATGCGCACTTTATC
CT 
818 
PDGFAa 
CGCTGATCCACTTTCTCG
TC 
TCACCTTATATCTGCTGT
GT 
578 
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6. Phenotypic Reversal by Hedgehog Inhibitors 
The zebrafish model has been spotlighted for its feasibility in in vivo screening of 
candidate drugs due to a lower cost and a higher efficiency than with mouse models. 
To investigate the feasibility of phenotypic reversal by Hh inhibitors, Tg(Ptf1a-
Gal4/UAS:GFP-UAS:Ihha) and control embryos were treated with the maximal 
tolerable dose (MTD) of either cyclopamine (15uM, Smo inhibitor) or HPI-4 [32] 
(5uM, ciliogenesis inhibitor working at downstream of Smo). Hh expression during 
embryonic periods induced pancreatic morphologic changes. Instead of a well-formed 
posterior pancreas in control, the Hh-secreting pancreas revealed a relatively prominent 
head with a short, slender, and tortuous posteriorly-growing pancreas. Whereas the 
length ratio of the posterior pancreas and head was between 1.5 and 2.0 in control at 5 
dpf, it was roughly 1.0 in the Hh-expressing pancreas, which was used as criterion for 
reversibility. The pancreatic phenotypes were effectively reversed by either HPI-4 or 
cyclopamine treatment when evaluated by fluorescence imaging (Fig. 9A, B). 
Next, groups of 12-day old Tg(Ptf1a-Gal4/UAS:GFP-UAS:Ihha) larvae were 
treated with Hh inhibitors for an extended period of up to 6 weeks. On histologic 
observation, the maximal tolerable dose (5uM) of HPI-4effectively prevented 
pancreatic fibrosis but induced prominent fatty infiltration of the pancreas (Fig.9C), 
which might need further investigation to have a further understanding of the 
underlying mechanism. However, contrary to HPI-4, cyclopamine failed to inhibit 
pancreatic fibrosis. This failure was possibly resulted from a low dose, due to dose-
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limiting toxicity (MTD: 500nm in juvenile fish) or from a different mechanism itself as 
the HPI-4 directly disturbs ciliogenesis leading to the disruption of Gli1/Gli2 activity. 
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Figure 9. Phenotypic reversal by Hh inhibitors. (A) Reversal of pancreatic 
phenotypes in embryos. Embryos were treated with either HPI-4 or cyclopamine from 
32 hpf until 5 dpf. Neither HPI-4 nor cyclopamine at the indicated concentrations 
impairs pancreatic development in controls. A well-formed pancreas in control 
produces a 1.5 to 2.0 times longer posterior pancreas compared to the head. Hh-
expression induces a short and slender posterior pancreas showing the ratio between 
the body and head by approximately 1.0. By the criterion for reversal of the 1.5 times 
or longer posterior pancreas, the Hh-induced pancreatic phenotypes are effectively 
reversed by either HPI-4 or cyclopamine treatment. (B) Whole mount ISH for ptf1a 
32and 5dpf.(C) Prevention of pancreatic fibrosis by a long-term treatment with Hh 
inhibitors. 12 day-old Ihha-expressing larvae were treated with Hh inhibitors for up to 
6 weeks. In the HPI-4 treated group (12 out of 16 survived), there is no evidence of 
pancreatic fibrosis but a somewhat prominent fatty infiltration (red arrows). Contrary 
to HPI-4, cyclopamine failed to inhibit pancreatic fibrosis in the surviving 11 zebrafish 
out of 14. Bars, 50 μm. 
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Figure 10. IHC for hedgehog ligands in human pancreas. (A, B) Immunostaining 
for Ihh and Shh in normal pancreas showing nil expression. (C) IHC for Ihh in chronic 
pancreatitis. Metaplastic ducts are strong positive for Ihh expression (arrows). (D) IHC 
for Shh in pancreatic cancer. Ductal cancer cells (arrow) and neighboring metaplastic 
ducts (arrowhead) are positive for Shh expression. Microscopic images are 400X. Bars, 
50 μm. 
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5. Discussion 
For the first time, current study presents a zebrafish model to study pancreatic 
fibrosis in which molecular events relevant to Hh-induced fibrosis can be explored. 
Zebrafish have recently been seen to simulate human disease in both molecular and 
histopathologic levels [18, 33]. In order to investigate the effect of Hh signaling in the 
pancreas, an experiment in which zebrafish orthologs of Hh ligands are over-expressed 
in the Ptf1a domain have been conducted. Along with a recent series of studies [10,15,  
20,34], the result provides strong in vivo evidence that Hh signaling operates in a 
paracrine mode in the pancreas. 
Among the three members of Hh ligands, Ihh and Shh expression is broader and 
strictly controlled in various organs, including the gastrointestinal system [5, 6, 35] 
Dhh expression is largely restricted to the gonads during the development [3, 36]. Thus 
subtypes of Ihh and Shh that are duplicated in zebrafish were chosen. Despite more 
prominent fibrosis by Shh expression, virtually identical phenotypes support functional 
redundancy between Ihh and Shh. 
The canonical Hh pathway involves ligands, receptors, intracellular mediators, and 
transcription factors. In the present study, aberrant expression of Ihha and Shha 
molecules in the exocrine pancreas caused progressive fibrosis by paracrine action. 
This leads to the destruction of acinar structures which mimics desmoplasia occurring 
in human chronic pancreatitis and pancreatic cancer. Although the paracrine action of 
Hh signaling during embryonic development has been well-documented [14, 37], there 
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have been debates on whether it works through a cell autonomous or non-autonomous 
mechanism, or both in pathologic conditions. In vitro studies have provided evidence 
of the autocrine activation of Hh signaling in keratinocytes, medulloblastoma, and 
renal cell carcinoma cells [17, 38, 39]. This is, however, not the case in the 
gastrointestinal tract and the pancreas, where Hh seems to work in an exclusively 
paracrine manner. Moreover, a similar mode of action has been demonstrated in 
fibrosis of the lungs and liver [11, 13,40]. Other studies have also demonstrated that Hh 
molecules directly enhanced migration and proliferation of fibroblasts in those organs 
[10, 41]. The study provides in vivo evidence that secreted Hh ligands cause pancreatic 
fibrosis by paracrine activation of responsive cells. The embryonic phenotypes in 
current models are not dramatic, they simply show morphologic changes of the 
exocrine pancreas. The development of the endocrine pancreas as well as other 
endodermal organs including the liver and the intestine were not affected by Hh over-
expression. The exocrine markers such as trypsin, elastase, and CPA are properly and 
timely expressed in acinar cells. These findings strongly support the fact that Hh-
expressing acinar cells are not influenced by this signaling but undergo proper 
differentiation. Although it is not clear whether the mode of action is dependent on cell 
type, the result suggests that a paracrine mechanism is highly involved in the pancreas. 
Chronic pancreatitis and pancreatic cancer represent human diseases that are 
accompanied by progressive pancreatic fibrosis. In both conditions, Hh ligands are 
considerably over-expressed in metaplastic ductal and cancer cells and play central 
roles in (Fig. 10) [7, 8, 19]. Pancreatic stellate cells residing in the vicinity of the acini 
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are the main source of proliferating fibroblasts in human disease. In the current models, 
the majority of the proliferating myofibroblasts in the pancreas seem to originate from 
the muscle layer of the bowel in the vicinity of the pancreas. Muscle layers of the large 
pancreatic ductal wall are a second source of proliferating myofibroblasts, as evidenced 
by thickened muscle layers which are immuno-reactive to α-SMA and Smo. The 
putative pancreatic stellate cells identified in the control pancreas by immuno-staining 
can be the third source of Hh-responsive cells. Therefore, it seems that Hh ligands 
indiscriminately recruit and activate myofibroblasts within the vicinity of Hh-secreting 
acinar cells. The pro-migratory effects of Hh signaling in multiple cell types have been 
well-documented, including neuronal and vascular endothelial cells as well as 
myofibroblasts [42-45]. The activation of Hh signaling is concentration dependent, and 
secreted ligands are effective up to 300um, which is the maximal distance they can 
reach by an unclear mechanism of molecular movement [46]. The close proximity 
between the pancreas and bowel in zebrafish allows secreted Hh molecules to reach 
and attract myofibroblasts from the gut wall. It is not clear if this phenomenon also 
occurs in the human pancreas, in which the distance between the pancreas and gut is 
much longer. It was also demonstrated that Hh-responsive myofibroblasts and ductular 
cells invariably express downstream components of Hh signaling. However, none of 
the acinar cells expressed these genes at either the mRNA or protein level. It is unclear 
as to how the Hh signaling exerts paracrine action in the pancreas, so it is crucial to 
determine responsiveness to secreted Hh molecules. In the current study, Hh-
responsive myofibroblasts invariable expressed Ptc1 and Smo even in control, 
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suggesting that expression of Ptc1 or Smo, or both determines Hh-responsiveness. 
Considering that Hh signaling is initiated by ligand-binding to the Ptc receptor, 
expression of the Ptc gene is mandatory for the initiation of Hh signaling. A recent 
observation has implicated that over-expression of Smo in pancreatic cancer-associated 
fibroblasts is a potential determinant for Hh-responsiveness [20]. It would be 
interesting to see whether forced co-expression of either Ptc1 or Smo, along with Hh 
ligands, might induce Hh responsiveness in acinar cells. 
This study suggests that the aberrant expression of Hh molecules does not induce 
tumors. The study have followed the transgenic zebrafish for more than one year 
without observing any evidence of tumor foci or PanIn-like lesions; as opposite to 
Pdx1-Shh mice that developed metaplastic duct and PanIn-like lesions with over-
expressed Ptc1 and Smo [19]. The discrepancy may be attributed to the difference in 
the regulatory element driving Hh expression or to the biologic difference between 
teleosts and mammals. Otherwise, the metaplastic duct and PanIn-like lesions in Pdx1-
Shh mice may actually be the counterparts of proliferating ductular structures found in 
our models. 
TGFß1 and MMPs as important mediators of Hh signaling have been identified. 
Recent observations have demonstrated that Hh signaling accelerates pancreatic 
tumorigenesis through tumor-stromal interaction by providing favorable conditions for 
tumor cells [21, 34]. The induction of TGFß1and MMPs expression in ductular cells 
gives an important hint as to how Hh signaling provides a favorable environment for 
tumor-stromal interaction during pancreatic tumorigenesis. Also, it provides theoretical 
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background evidence that inhibition of Hh signaling is beneficial for the treatment of 
pancreatic cancer. In fact, recent observation has suggested that inhibition of Hh 
signaling can provide additional benefits to anti-tumor effects of conventional 
chemotherapy [47, 48]. A cross-sectional study has strictly demonstrated co-expression 
of TGFß1 and Hh molecules in epithelial compartments [13], and crosstalk between 
Shh and TGFß pathway has also been documented in vivo during embryonic 
development [49]. In vitro studies have shown that TGFß cooperates with canonical Hh 
signaling to activate Gli proteins and Hh target gene expression [50, 51], and 
exogenous Shh induces TGFß secretion in gastric cancer cells [52]. Therefore, the 
emergence of TGFß1-expressing ductular cells in current models harbors important 
implications. Though requisites for Hh-responsiveness need to be investigated, 
epithelial cells are indeed capable of responding to Hh ligands. Moreover, TGFß1 may 
be one of the targets that are induced by Gli-mediated transcriptional regulation, which 
may aggravate pre-existing conditions such as chronic pancreatitis and pancreatic 
cancer. The TGFß1 expression, however, is not primarily responsible for pancreatic 
fibrosis because fibrotic change was evident even at the first month when TGFß1-
secreting ductular proliferation was not observed. 
Similarly, MMPs play roles by remodeling the extracellular environment, which is 
an important step in the progression of fibrosis as well as tumorigenesis. In this study, 
Hh-responsive cells demonstrated the striking up-regulation of MMP9 with modest 
elevation of MMP2 and MT1-MMPs.This factor is consistent with in vitro 
observations that have demonstrated either exogenous Hh molecules or ectopic 
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expression of Gli1 or Hh molecules induced MT1-MMP and MMP9 in cultured cells 
[53, 54]. MMPs induced by Hh signaling remodel the extracellular matrix and promote 
migration of activated Hh-responsive cells, which accelerates the fibrotic process. The 
in vivo environment enables exploration of epiphenomena manifested by the complex 
interaction of different types of cells. Thus, reflection of what really happens in the 
context of the physiologic and pathologic conditions is more than an in vitro study can 
provide. 
While chronic pancreatitis accompanies the infiltration of inflammatory cells, the 
pancreatic pathology in these Hh-expressing zebrafish lacks an inflammatory reaction. 
Considering that the eventual pancreatic dysfunction in human chronic pancreatitis 
results from long-standing fibrotic change, acinar destruction and prevention of fibrosis 
is one of the main therapeutic targets. As a model, the zebrafish uniquely allows in vivo 
screening for small molecules, in which the effect of given drugs as well as toxicity can 
be simultaneously monitored under physiologic conditions. A visible short-term 
phenotype can facilitate high-throughput screening of candidate drugs. Although this 
model could not thoroughly explain how the morphologies of a developing pancreas 
were changed by Hh expression, the study could observe phenotypic reversal by 
treatment with Hh inhibitors. The study also demonstrated that pancreatic fibrosis and 
destruction were effectively prevented by the treatment of HPI-4, a ciliogenesis 
inhibitor, but not with cyclopamine. Although failure by cyclopamine may be attributed 
to the dose limitation such as the high toxicity in the larval stage, this finding implies 
that targeting downstream of Smo may be beneficial for obtaining a therapeutic effect. 
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Though the mechanism for differential sensitivity between embryos and larvae was 
unclear at the time, the acquisition of a toxicity profile in a physiologic context is an 
additional benefit of using the zebrafish as a model for drug screening. This study 
provides in vivo evidence that inhibition of Hh signaling is a viable option for the 
prevention of pancreatic fibrosis which has a detrimental effect on chronic pancreatitis 
and pancreatic cancer. 
In conclusion, aberrant expression of either Ihha or Shha causes progressive 
pancreatic fibrosis through paracrine activation of Hh-responsive cells. This study 
identified TGFß and MMPs as important genes induced by Hh signaling in responsive 
cells. These transgenic models will be a valuable platform in exploring the mechanism 
of fibrogenic pancreatic diseases caused by Hh signaling activation. 
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Chapter 2 
Interleukin-6 mediated chronic inflammation induces 
hepatocellular carcinoma in transgenic zebrafish 
1. Abstract  
Chronic inflammation is an important process leading to carcinogenesis. Therefore 
targeting and controlling inflammation can be a promising cancer therapy. 
Inflammation is often caused by a variety of inflammatory cytokines. Interleukin-6 (IL-
6), a pleiotrophic cytokine, is not only involved in the regulation of regenerative 
process, but also in immune and inflammatory responses in various carcinogenesis 
including liver cancer. Yet, the nature of its involvement in tumorigenesis is still 
unclear. Although animal models have been widely used to elucidate the nature of IL-
6's involvement in hepatic tumorigenesis, to date, no animal model revealing direct 
consequence of the inflammatory IL-6 expression and hepatic tumorigenesis have been 
suggested. In this study, an in vivo hepatic tumorigenesis model using transgenic 
zebrafish was generated to demonstrate IL-6 driven tumorigenesis. Transgene 
expression under the regulation of LFABP promoter driving hIL6 gene was found 
starting from embryonic day 4 and persisted until adulthood. Interestingly, the aberrant 
hIL6 gene expression, specifically expressed in the zebrafish liver, caused a chronic 
inflammation accompanying infiltration of inflammatory cells of myeloid and B cell 
lineage. The inflammation induced cell damage and compensatory proliferation. This 
eventually resulted in the generation of precancerous dysplastic lesions including clear 
cell foci, large cell changes, and eosinophilic and also basophilic bodies. 
Hepatocellular carcinoma developed in a subset of the transgenics was finally observed. 
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Molecular analyses revealed up-regulation of majority of the components involved in 
the IL-6 driven pathway during inflammatory process as evidenced by quantitative RT-
PCR and Western blot, supporting that the aberrant high level of IL-6 production in the 
liver causes hepatic tumorigenesis. Among the downstream pathway from IL-6, while 
PI3K/Akt pathway activation was confined to inflammatory cells, activation of 
Jak/Stat3 pathway was noted in inflammed hepatocytes as well as in cells at dysplatic 
foci, suggesting Jak/Stat3 pathway played dominant role in the hepatic tumorigenesis. 
Conclusion: As far as we know, the current transgenic zebrafish most closely mimic hepatic 
carcinogenesis in human induced by chronic B or C viral infection at both cellular and 
molecular level. We provide a straightforward evidence of relationship between chronic 
inflammation and tumorigenesis, and reinforces the pivotal role of IL-6 in 
inflammation-associated hepatocellular carcinoma.  
 
Key words: Transgenic zebrafish, Interleukin-6, Inflammation, Dysplastic foci, 
Hepatocellular carcinoma 
 
2. Introduction  
The liver is the largest internal organ and plays a major role in systemic 
metabolism in human. The organ must not only be able to produce biochemicals 
necessary for digestions, it must also be able to protect against damage by ingested 
agents, drugs. Hepatic immune system functions to identify, detoxify, and neutralize 
pathogens and failure of this immune system can cause chronic inflammation which 
leads to hepatic carcinogenesis. It is well known that the immune-mediated liver 
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damage is played by apoptotic death pathway, whereas acute liver damage caused from 
a variety of drugs and poisons is occurred by oxidative damage of the hepatic cells.[1-
2] 
IL-6 is a highly versatile cytokine which was originally characterized as a regulator 
that stimulates the final maturation of B cell. [17] This cytokine is also known to 
promote hepatic survival by stimulating liver regeneration. [3-5] IL-6 is closely related 
to NF-κB which increases the IL-6 secretion following hepatectomy. Upon binding of 
the IL-6 to its receptor, Janus Kinase (JAK) is activated and in turn the kinase activates 
the MAPK and STAT3 pathways, blocking and reducing apoptotic cascade and 
oxidative injury, respectively. [6, 7, 13] This results in promoting hepatic regeneration 
by a rapid transition from quiescence into cell cycle of hepatocytes. Thus, IL-6 plays a 
crucial role in regulating the regeneration of hepatocytes after hepatectomy, 
functioning as a critical proregenerative factor and acute-phase inducer in the liver 
injury.  
In contrast, however, growing evidences indicating that IL-6 levels are elevated in 
various cancer tumorigeneses associated with chronic inflammation have been reported 
in different cancer types. Inappropriately high level of IL-6 production has been 
detected in breast cancer mammospheres.[8] A non-small-cell lung adenocarcinoma 
has also provided additional evidence for the involvement of IL-6 in tumorigenesis.[9] 
These reports raise the question that elevating the cytokine level is implicated in 
tumorigenesis. In fact, a previous study showed that high IL-6 level rather inhibit liver 
regeneration by increasing expression of p21, the cyclin dependent kinase inhibitor 
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(CDKI), after hepatectomy in mice.[14] Taken together with the reports showing IL-6 
as a proregenerative factor of hepatocytes, IL-6 contains both pro- and anti-mitogenic 
actions, suggesting that its signaling process might be regulated by a negative feedback 
loop. STAT3 is a transcription factor involved in inflammation and tumorigenesis. In 
response to IL-6, the transcription factor is translocated to nucleus and turns on strong 
negative feedback loops involving suppressor of cytokine signaling 3 (SOCS3), the 
major negative regulator of IL-6 dependent signaling.[24] This event that leads to 
STAT3 regulation in human HCC is not fully understood.    
In the past decade, zebrafish has been used as an experimental model for human 
diseases, including human liver cancer.[10-12] It has been demonstrated that the 
zebrafish and human tumor have molecular and cellular conservation at various levels, 
indicating the potential of zebrafish for modeling human cancer. [15-16] In the present 
study, a novel transgenic zebrafish line was generated and validated to demonstrate a 
clear in vivo evidence that the hepatic expression of IL-6 induces chronic inflammation 
leading to hepatic tumorigenesis.  
 
3. Materials and Methods 
1. Transgene constructs and transgenesis.  
All constructs used in our study were sequenced and verified using the appropriate 
primers listed in Table 1. For transgenesis, LFABP-Gal4 and UAS-hIL6 fish were 
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established and crossed for targeted expression of transgene in the liver by a binary 
expression system (Fig. 1A).[28-29] Using polymerase with a proofreading function 
(Invitrogen, Grand Island, NY), 2.8kb upstream of LFABP gene was PCR-amplified as 
referenced by a previous report.[19]  The PCR product was then cloned into ApaI/NcoI 
site of pUAS-GFP-Kras-pA construct, replacing the pUAS region to give a construct of 
pLFABP-GFP-Kras-pA. Gal4VP16 sequence was also PCR-amplified by using F-
Gal4-NcoI/R-Gal4-ClaI primer and inserted into NcoI/ClaI sites of pLFABP-GFP-
Kras-pA to generate pLFABP-Gal4VP16-pA. Human interleukin-6 cDNA was 
purchased from Open Biosystems (Huntsville, AL). This cDNA was then cloned into 
mluI/nheI sites of the pUAS-GFPpA-Kras to give pUAS-IL6pA-Kras. To facilitate 
identification of transgenics, Cmcl2-GFP (for Cardiac expression of GFP) was PCR-
amplified and cloned into the pUAS-IL6pA-Kras which gives the final construct, 
pUAS-hIL6-pA-Cmcl2-GFP-pA. pUAS-RFP was prepared by placing RFP sequence 
under the pUAS promoter.  
 Each injection mixture was prepared by reconstituting Tol2-transposase mRNA (20 
ng/ul) and transgene construct (20 ng/ul) in Danieu’s buffer mixed with 0.03% phenol 
red. UAS-RFP embryos at single-cell stage were transferred to a molded agarose dish 
and 4 pL of the injection mixture of pLFABP-Gal4VP16-pA was introduced by yolk 
injection using a MMPI-2 microinjector. F0 founder embryos showing RFP expression 
in the liver were selected under a fluorescence microscope (Olympus, Japan). The 
embryos were raised and bred to give a birth to F1 Tg (LFABP-Gal4) zebrafish. 
Injection mixture of pUAS-hIL6-pA-Cmcl2-GFP-pA was introduced into AB (wild 
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type) embryos and cardiac GFP was utilized as a biomarker for gene transmission. By 
crossing Tg (LFABP-Gal4 / UAS-RFP) and Tg (UAS-hIL6-CG), transgenic zebrafish 
expressing hIL6 in the liver was established. All transgenes were transmitted in normal 
Mendelian ratio. 
2. Animal stocks and embryo care.  
All zebrafish were raised in a standardized aquaria system (Genomic-Design Co., 
Daejeon, Korea) according to standard protocols at 28°C on a 14- to 10-hour light and 
dark cycle. Embryos to be processed for whole mount analyses were placed in an E3 
media with 0.003% phenylthiourea at 24 hpf to inhibit pigmentation. This experiment 
strictly followed the Guidelines for the Welfare and Use of Animals in Cancer 
Research. 
 
3. Histology, immunohistochemistry staining (IHC). 
Histologic evaluation was performed using 4-μm sections of 4% paraformaldehyde-
fixed, paraffin-embedded tissues. Hematoxylin and eosin (H&E) staining was 
performed according to standard protocols. [21] Gene expression analyses were carried 
out either by IHC if an antibody cross-reactive to zebrafish was available, or by ISH as 
previously described. [15, 21]  The sections were deparaffinized and rehydrated, and 
were then subjected to antigen retrieval performed according to several recommended 
methods. The endogenous peroxidase activity was blocked using 0.3% hydrogen 
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peroxide. Primary antibodies were rabbit anti-IL6 (1:200), rabbit anti-Caspase 3 
(1:100), mouse anti-proliferating cell nuclear antigen (PCNA) (1:2000), rabbit anti-
JAK1 (1:200), from Abcam (Cambridge, MA), mouse anti-phospho-PI3K (1:100), goat 
anti-AFP (1:200), from Santa cruz Biotechnology, Inc. (Santa Cruz, CA),  rabbit anti-
phospho-Tuberin/TSC2 (1:200), rabbit anti-phospho-mTOR (1:200), rabbit anti-
phospho-4EBP1 (1:200), rabbit anti-phospho-RS6K(1:200), rabbit anti-Stat3 (1:200), 
and rabbit anti-phospho-Stat3 (1:200), from Cell Signaling (Danvers, MA). The 
primary antibodies were applied and incubated for overnight at 4 °C. After washing, 
the HRP-conjugated secondary antibody was applied, and samples were further 
incubated for 60 min at room temperature. Finally, the sections were colored using 
REAL EnVision Detection System, Peroxidase/DAB+, Rabbit/Mouse Kit (DAKO, 
Hamburg, Germany). For observation, slides were counterstained with hematoxylin 
and mounted with Histomount (Zymed, San Francisco, CA). 
 
4.  In situ hybridization (ISH). 
To generate a riboprobe for hIL6, cDNA was amplified by PCR ( hIL-6  sense: 5’-
ATAACGCGTACCATGAACTCCTTCTCCACAAGC-3’, antisense; 5’-
ATAGCTAGCCTACATTTGCCGAAGAGCCC-3 ’) then cloned into pCRII vector 
(Invitrogen, Carlsbad, CA), a TA cloning vector. Plasmids were linearized and 
antisense riboprobe was generated by in vitro transcription using digoxigenin labelling 
mixture (Roche Diagnostics GmbH, Mannheim, Germany). Control sense probes were 
run in parallel for all experiments. Experiments were performed using either whole 
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embryos or 4um section slides. Specimens were fixed in 4% paraformaldehyde (PFA) 
on rotate for overnight at 4 °C, dehydrated in a graded methanol series and stored in 
100% MeOH. Samples were reconstituted in PBS with 0.1% Tween20 (PBST) and 
treated with 5mg/ml Proteinase K for 20 min 20 min at room temperature. Rehydrated 
samples were prehybridized with 50% formamide, 5X SSC, 50ug/mL heparin, 9.2 mM 
citric acid, 0.1% Tween-20, and 500ug/mL Torula yeast RNA (Sigma, St. Louis, MO) 
for 3 h at 65°C followed by overnight hybridization with DIG-labeled RNA. Post-
hybridization washes were done at 68 °C at least 4 hours as follows  2 washes in  
2×SSC 0.1% Tween-20 for 10 minutes, one wash in 2×SSC 0.1% Tween-20 for 10 
minutes followed by two washes in 0.2×SSC 0.1% Tween-20 for 30 minutes. All 
washing solutions were pre-warmed to 65°C. Subsequently, specimens were rinsed 
twice with PBST.  Tissue was incubated in Anti-DIG alkaline phosphatase antibody 
(Roche) in blocking overnight at 4 °C. Tissue was washed in PBST After extensive 
washing, samples are visualized by incubating with NBT/BCIP AP substrate solution 
(Roche Diagnostics GmbH)  in 0.1 M Tris–HCl, pH 9.5, 0.1 M NaCl, 50 mM MgCl2, 
0.1% Tween 20. Whole mount embryos were immersed in glycerol for better 
visualization. The sections were counterstained with neutral red and mounted with 
Histomount. 
 5. Imaging  
An Olympus MVX10 was used for whole mount embryo imaging. Photographs 
from slide sections or live embryos were obtained using an Olympus BX51 or a 
confocal microscopy (Carl Zeiss 700, Germany).  
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6. RT-PCR 
Real-time PCR was performed by using dissected liver tissue from 3-month-old 
zebrafish. The co-expressed GFP enabled precise dissection of the tissue. For each 
group, samples were collected from 3-4 zebrafish and using TRIzol reagent® 
(Invitrogen, Carlsbad, CA). cDNA was synthesized using a Maxima First Strand cDNA 
Synthesis Kit for RT-qPCR (Thermo Scientific Fermentas, K1641, Glen Burnie, MD, 
USA). Quantitative real-time PCR was performed using Maxima SYBR Green/ROX 
qPCR Master Mix (Thermo Scientific Fermentas, K0222, Glen Burnie, MD, USA) and 
the 7300 Real Time PCR System (Applied Biosystems, Foster city, CA). Samples were 
triplicated and all experiments were repeated three times using individually prepared 
samples. Primer sequences for RT-RCR are shown in Table  2.  
7. Western blotting 
Whole cell extracts were prepared from liver of zebrafish as described previously 
[28]  A 20 mg sample of whole cell extract was separated on an 10% SDS–
polyacrylamide gel and transferred to PVDF (Polyvinylidene fluoride) membrane 
(Amersham, GE Health, Sweden) using semidry transfer (GenScript NJ, USA). Filters 
were stained for 10 minutes with Ponceau S, blocked for 1 h in 5% nonfat dry milk in 
phosphate-buffered saline (PBS) with 0.1% Tween 20, incubated over night at 4°C 
with a primary antibody in blocking buffer, washed 4 times with PBST, and incubated 
for 1h with horseradish peroxidase-conjugated secondary antibody. Labeled proteins 
were detected by ECL reagents and Hyperfilm ECL (Amersham Biosciences).   
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8. Treatment with IL6 pathway inhibitors 
To counteract active Il6 signaling in live zebrafish, BKM 120 (PI3K inhibitor sc-
364437; Santa Cruz Biotechnology, Santa Cruz, CA). AZD 1480(JAK1 inhibitor sc-
364735; Santa Cruz Biotechnology, Santa Cruz, CA) and Cucurbitacin I (Stat3 
inhibitor sc-203010; Santa Cruz Biotechnology, Santa Cruz, CA)were used to block 
downstream signaling. To determine treatment doses, 8-weeks old embryos were 
treated with a serial escalation of each inhibitor for 7days. Of the Maximal tolerable 
doses (MTDs) that caused fatality no more than 25% were selected; which were 1uM, 
10nM, and 10nM for BKM120 (BKM120 is a potent and cell permeable inhibitor of 
the PI 3-kinase family. Specifically inhibits p110α, p110β, p110γ and p110δ with IC50 
of 52 nM, 166 nM, 262 nM and 116 nM, respectively) , AZD1480( AZD1480 is a 
novel ATP-competitive inhibitor of JAK1 (IC50 = 1.3 nM) and JAK2 (IC50 = 0.26 
nM) ), and Cucurbitacin I( HL-60: IC50 = 0.1 nM (human); U-937: IC50 = 0.3 nM 
(human); HT-1080: IC50 = 0.47 nM (human); HT-29: IC50 = 190 nM (human); Integrin 
αL: IC50 = 950 nM (human) ) respectively. First, groups (20 per group) of 6–weeks old 
LFABP-Gal4/UAS-hIL6 juvenile fish were separately treated with the each inhibitor in 
1L-water tanks up to 8 weeks then processed for histology.  
9. Statistical analyses  
Statistical analyses were performed using SPSS ver. 11 software. P < 0.05 was 
considered to be a statistically significant difference. All tests were performed with 
SPSS 10.1 software (SPSS Inc., Chicago, IL, USA). 
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4. Results 
1. Sustained expression of hIL6 induces chronic inflammation in the liver.  
Different transgenic zebrafish lines to demonstrate hIL6 driven tumorigenesis have 
been generated. In order to do this, independent transgenic lines of Tg (UAS-hIL6-CG) 
were established and crossed with Tg (LFABP-Gal4 / UAS-RFP). Binary expression 
by a Gal4-UAS system has allowed a faithful expression of the hIL6 gene in the 
zebrafish liver (Fig. 1A). RFP expression and ISH experiment confirmed that the 
transgene expression was apparently detected from 4 days post-fertilization (dpf) and 
persisted until adulthood, suggesting that the stable Tg lines, LFABP-Gal4 / UAS-RFP 
/ UAS-hIL6-CG and LFABP-Gal4/UAS-RFP for experimental and control lines, 
respectively, were established (Fig. 1B). By selecting the transgenic lines under a 
fluorescence microscope, the heterozygote zebrafish were then maintained and used for 
all experiments. The result showed that a sustained expression of hIL6 specifically in 
the hepatocytes induced chronic inflammatory change of the liver (Fig. 2). Massive 
infiltration of inflammatory cells was noted at 1 month of age in hepatic sinusoids and 
intrahepatic vessels, which was ruthlessly appeared in all transgenic zebrafish 
expressing hIL6 gene in hepatocytes. The infiltrated inflammatory cells then caused 
destruction of normal hepatic architecture (Fig. 2 ).  
Inflammatory changes of the liver induced cell damage and compensatory 
proliferation of hepatocytes, which resulted in increased reactivity to active caspase 3, 
PCNA immunostaining, and cyclinD (Fig. 3). Infiltrated inflammatory cells were 
identified by ISH for myeloid and B cell lineage. While control liver was scanty of 
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inflammatory cells, IL6 expression markedly increased myeloid and B cells in the liver 
(Fig3).   
  
2.  Hepatocellular tumorigenesis caused by hIL6 expression.  
Dysplastic foci began to appear at 2 months of age. Various precancerous lesions 
were noted in the liver of hIL6-expressing transgenic zebrafish, including clear cell 
bodies, eosinophilic and also basophilic cell bodies (Fig. 4). A typical cytology of 
hepatocellular carcinoma such as eosinophilic granular cytoplasm, rounded nuclei and 
prominent nucleoli was often detected from the observation. Large cell changes and 
hyaline bodies which are also the characteristics of tumorigenesis were shown in the 
transgenic zebrafish liver. Furthermore, individual liver of the transgenic zebrafish 
frequently harbors multiple foci of dysplasia of different types, indicating that 
carcinogenic process was polygonally occurred from multiple areas. Further 
investigation of the transgenic zebrafish observed that dysplastic foci were occurred in 
all transgenic zebrafish at 3 months of age, revealing 100% penetrance. Among the 
dysplastic foci, clear cell bodies were the most common phenotype. Overt 
hepatocellular carcinoma began to appear at 6 months of age. Taken together, our 
histological observation revealed that the hIL6-expressing transgenic zebrafish has 
developed a hepatocellualr carcinoma. Immunohistochemical staining revealed 
markedly increased reactivity to PCNA in dysplatic area (Fig. 4k). Overt HCC cells 
were positive to αFP (Fig. 4l).   
3. Up-regulation of inflammatory and carcinogenic pathway by the 
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chronic expression of hIL6. 
 Upon binding of IL6 to its receptor, pleiotropic effects are transduced through 
different intracellular signalings, which includes PI3K-Akt pathway, Jak/Stat3 
pathway, and Ras-Raf-Mapk pathway. PI3K-Akt pathway is an intracellular signaling 
pathway important for carcinogenesis, contributing to cellular proliferation and 
survival.29 Jak/Stat3 pathway is also known for tumor cell survival through the up-
regulation of anti-apoptotic genes and function of Ras-Raf-Mapk pathway is to 
transduce signals for cell growth, division and differentiation.30, 31 Thus, a list of genes 
that might be modulated by the aberrant expression of hIL6 in these pathways was 
selected and summarized into three categories, inflammation, survival, and 
proliferation for quantitative real-time PCR (qRT-PCR) (Primers are listed in Table 2). 
For this qRT-PCR experiment, whole livers collected from four zebrafishes of each 
group were used. The result indicated that chronic expression of hIL6 induced up-
regulation of various components of the pathways (Fig. 5). The genes involved in 
inflammatory process such as c-Myc, Pim1, Socs1a, Socs2, Socs4, and Tgfb1a were 
especially noted to be increased by many folds. Among these, interestingly, c-Myc 
known as a regulator of cell growth showed over 20 fold increasing of its expression. 
The most prominent expression change was observed from Surv2, a member of 
Survivin family containing anti-apoptotic activity. Other genes involved in PI3K-Akt 
and Jak/Stat3 pathways were also up-regulated, suggesting that sustained expression 
of hIL6 has induced activation of inflammatory and carcinogenic pathway.  
     To further determine whether the molecular up-regulation is actually caused by the 
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chronic expression of hIL6, western blot analyses were done (Fig. 5C). The experiment 
was done using pooled samples of dissected livers from 3-month old transgenic 
zebrafish. As shown in the fugure 3C, the transgenic zebrafish contained high level of 
hIL6 expression while non-transgenic zebrafish did not show the protein expression. 
This is consistent with the RT-PCR result (Fig. 5). Antibody against pMAPK1, pPI3K, 
and pSTAT3 clearly detected the proteins that show up-regulation in the transgenic 
zebrafish. The result showed a consistency with the gene expression analyses, 
suggesting that hIL6 expression has actually activated all downstream signaling 
pathways in the zebrafish liver.  
 
4. Histologic analyses by IHC and ISH revealed predominant activation 
of Jak/Stat3 pathway in the hepatocellular tumorigenesis.  
Our molecular analysis revealed that IL6 action in conducting tumorigenesis 
involves up-regulation of downstream genes in inflammatory pathway. The 
inflammation associated tumorigenesis of the transgenic zebrafish liver might be 
resulted from Jak/Stat3 signaling. To find out this, immunohistochemical analysis and 
ISH were done (Fig. 6,7). In fact, antibody against caspase 3 showed a clear positive 
visualization in abundant hepatocytes of the transgenic zebrafish liver, suggesting that 
induced cell death occurs, whereas control did not show any positive sign (Fig. 3c and 
d). Strong reactivity of hepatocytes in dysplatic foci to PCNA suggested that the 
dysplastic foci were true neoplastic lesions. To delineate PI3K/Akt pathway, 
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immunostaining was performed for pPI3K, pAkt, pTuberin, and pRS6k. Among the 
dysplastic foci, only hepatocytes showing large cell change were reactive to pTuberin, 
pRS6k, and pAkt, while immunostaining against pPI3K in hepatocytes of the 
dysplastic foci were not reactive (Fig6). Interstingly immunoreactivity to pPI3K was 
noted in infiltrated inflammatory cells. These finding suggested that activation of 
PI3K/Akt signaling is not a crucial finding in IL6-induced hepatic carcinogenesis. On 
the contrary, immunoreactivity to pStat3 was robust in non-neoplastic inflamed 
hepatocytes, hepatocytes in dysplastic foci, and in hepatocellular carcinoma, 
suggesting activation of Jak/Stat3 pathway played an important role in IL6-induced 
carcinogenesis (Fig 7). Downstream genes induced by active Jak/Stat3 pathway were 
evaluated by ISH. As expected hepatocytes in inflammation and dysplactic foci 
revealed robust expression of those genes, suggesting actual activation of Jak/Stat3 
pathway in IL6-expressing hepatocytes. Above findings suggest Jak/Stat3 is a crucial 
pathway leading to carcinogenesis in the current IL6-induced HCC model.  
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Fig 1. Transgenesis. A. Strategy of transgenesis. Transgenic constructs allowing Tol2-
mediated transgenesis. Experimental line was maintained as Tg (LFABP-Gal4) / 
(UAS-RFP) / (UAS-hIL6) and control line as Tg (LFABP-Gal4) / (UAS-RFP). B. 
Transgene expression. a-c Tg(LFABP-Gal4/UAS-RFP) zebrafish. d-f. Tg(LFABP-
Gal4) / (UAS-RFP) / (UAS-IL6-CG). Transgene expression is noted as red 
fluorescence in the liver and as green fluorescence in the heart. Cardiac GFP are to 
facilitate selection of transgenic embryos. b,e. ISH for IL6 in 4 dpf transgenic embryos 
showing strict RNA expression in the liver. c,f. IHC for IL6 in liver section from 2 
month old zebrafish showing expression in hepatocytes.  Microscopic images are 
400X. Bars, 50 μm. 
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Fig 2. Liver inflammation by IL6 expression. a. Control. b-f. Tg(LFABP-Gal4/UAS-
IL6) zebrafish. Variable degree of chronic inflammation of the liver is frankly evident 
at 1 month of age. b. Massive infiltration of inflammatory cells destructs liver 
architecture. e. Inflammatory cells in hepatic sinusoids.  f. Inflammatory cells in the 
hepatic vasculature.  
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Table 1. Primers used for the generation of transgene contructs. 
Primers Sequence 
F-LFABP-Apa1 5’-ACTAGGGCCCTCGATCTGCTGCAGTTCGAA-3’ 
R-LFABP-Nco1 
5’-ATACCATGGGCTTTCTGGAGAAGCTCAAC-3’ 
F-Gal4VP16-Nco1 
5’-ATACCATGGAGATGAAGCTACTGTCTTCTATCG-3’ 
R-Gal4VP16-Cla1 
5’-ACTAATCGATCTACATATCCAGAGCGCCG-3’ 
F-hIL6-Mlu1 5’-ATAACGCGTACCATGAACTCCTTCTCCACAAGC-3’ 
R-hIL6-Nhe1 5’-ATAGCTAGCCTACATTTGCCGAAGAGCCC-3’ 
F-Cmcl2-Nde1 
5’-GAATTCCATATGAAAGCTTAAATCAGTTGTGT -3’ 
F-EGFP-Xho1 
5’-
ATACTCGAGCTCAAGCTTATGGTGAGCAAGGGCGAGG
AG-3’ 
R-EGFP- Cla1 
5’-ACTAATCGATTTACTTGTACAGCTCGTCCAT-3’ 
F-RFP -Nco1 
5’-ACTACCATGGCCTCTTTGCTGAAGAAGA -3’ 
R-RFP- Cla1 
5’-CCATCGATTCAGTTGTGGCCCAGCTTGG-3’ 
F-UAS-Xho1 5’-ATACTCGAGCTCTGCTAACCATGTTCATG-3’ 
F-UAS-Seq 5’-TCAGCCTCACTTTGAGCTCC-3’ 
 
F-UAS-Seq was used for sequence verification of constructs. Underlined GCCACC sequence 
was inserted for Underlines, restriction enzyme sequences 
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Fig 3. Chronic inflammation induced cell damage and proliferation. a,b. IHC for 
IL6. Inflammed hepatocytes are positive for IL6. c,d. IHC for caspase3a showing 
increased cells with positivity e,f. IHC for PCNA showing markedly increased 
positivity in IL6-expressing liver. g,h. Immunoreactivity to cyclinD1 was also 
markedly increased. i,j. ISH for Ighm, a B-cell marker, showing some infiltrated 
inflammatory cells positive for Ighm. k,l. ISH for Spi1, a myeloid marker, showing 
reactive cells. i,k. Inlet image is spleen as positive internal control. Microscopic images 
are 400X. Bars, 50 μm. 
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Fig 4. Histologic changes of the liver by interleukin 6 expression.  a-i. H&E stain. 
a,b. Low power (100X) views showing  multiple foci of dysplasia.  c. High power 
(400X) view of a clear cell body. Hepatocytes adjacent to the clear cell body also show 
anaplasia. d. An eosinophilic cell body.  e. A basophilic cell body. f. Hyaline-like body 
changes of hepatocytes suggesting altered cytoskeleton.  g,h. Large cell changes of 
hepatocytes.  i. Overt hepatocellular carcinoma showing severe cellular anaplasia and 
occasional mitosis. j. IHC for IL6. Dysplatic hepatocytes are positive for IL6. k. IHC 
for PCNA showing markedly increased positive cell at a dysplatic focus. l. 
Immunostaing for αFP in an area of HCC showing frequent positive cells.  
Microscopic images are 400X. Bars, 50 μm. 
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Fig 5. RT-PCR and Western blot. Samples were prepared from whole livers 
dissected under a fluorescence microscopy from 3-month old zebrafish. (A) Real-time 
RT-PCR showing differential expression of the components of the PI3K-Akt, Jak/Stat3 
pathway, and Ras-Raf-Mapk pathway. Most genes induced by Jak/Stat3 pathway 
including Appa, c-Myc, Socs1a, Socs2, Socs2, Cis, Pim1 are up-regulated. Note the 
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prominent up-regulation of Myca and surv2. (B) Electrophoretic images of RT-PCR 
products recapitulate real-time PCR findings. (C) A western blot hybridization 
showing up-regulation of active phosphorylated downstream compoments. hIL6, 26 
kD; MAPK1, 52 kD; p-MAPK1, 52 kD;  p- PI3K, 85 kD; p-STAT3, 86 kD; Caspase3-
A, 35 kD; ß-actin, 45 kD. C, Tg(LFABP-Gal4/UAS:RFP); IL6, Tg(LFABP-
Gal4/UAS:Hil6-CG/UAS-RFP). (* P<0.05 versus control. 
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Fig 6.  IHC for components of PI3K pathway. As downstream components IHC was 
done for active forms of PI3K, Akt, 70S6K, tuberin, and 4EBP1. a. Control. b-i. 
Tg(LFABP-Gal4/UAS-IL6). a-d. IHC for phophorylated form of PI3K showing 
positive staining only in infiltrated inflammatory cells. However, dysplatic hepatocytes 
with large cell chages are positive for pPI3K. e,f. IHC for pAkt with HCC at 9 monhts  
reveals small subset of tumor cells positive. g,h. IHC for pRS6K showing positive 
reaction only in hepatocytes with large cell changes. i,j.  pTuberin staining is also 
positive in large cells. k,l. IHC for p4EBP1 showing positive saining in hepatocytes 
with large cell changes.  Bars, 50 μm. 
 
 83 
 
 
 
Fig 7. IHC for Jak/Stat3 components. a-d. IHC for pStat3. Virtually all hepatocytes 
are positive for pStat3 in Tg(LFABP-Gal4/UAS-IL6). c. Note that hepatocytes in 
dysplastic focus are strongly reactive pStat3. c,d. While hepatocytes are postive for 
pStat3, infiltrating inflammatory cells are not (red arrowhead). e-i. ISH for genes 
induced by Jak/Stat3 pathway. Inflammed and dysplastic hepatocytes express Socs1, 
Appa, Cis, and Pim1. k. Inlet image is spleen as positive internal control.  Bars, 50 μm. 
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Table 2. Primers used for RT-PCR. 
 
.Genes 
Sense (5’-3’) Antisense (5’-3’) 
Product 
length 
(bp) 
zAppa TTATTCCCGATGCAGCTCT
T 
ATGGGTATAGACCGCACGGT 151 
zApaf ATGGAGGAACGTGCCCGC
A 
GGCCTTGCTGAGCACTTTTG 141 
zBax ATACGGGCAGTGGCAATG
AC 
GTTTATGGCTGGGGTCACAC 153 
zBcl2 GGACTGATGGGGCTGAAG
AG 
CCTCCTTCACTGCGTCTAGA 171 
zβ-Actin ATGGATGAGGAAATCGCT
GC 
CTTTCTGTCCCATGCCAACC 151 
zCcnD1 GCACCAGTTGTTTTGCTGC
G 
GACCTCGAGCATCCACGTCG 196 
zCis TGCCTTTCTCTTCACCGAG
A 
AACAGAGTGGGCCTCACTG
G 
152 
zMc11a AGTTTGGATTTTAGGCGAA
C 
AACAAATCGACCGTCCAGCT 183 
z4EBP1 ATGTCCATGGGCAGTCAGA
AG 
GCAGGAACTTTCGGTCATAG 169 
zEif1a GACTGCTGAACCGGAAAC
TT 
CCTCCACGGTGTCAAACTTT 200 
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zErk1 CTGGAGTCGGTGAAGGGA
CA 
GCTGGCAGTAGGTCTGGTGT 169 
zIL1b CATGCGGGCAATATGAAG
TC 
CATTTTGTGCTGCGAAGTCC 170 
zIL12a ATGAAGATCTGTATTGTGAT
TAGCA 
AAAACCAGCAAACAAGTCC
T 
177 
zMCl1a AGTTTGGATTTTAGGCGAA
C 
AACAAATCGACCGTCCAGCT 183 
zMCl1b ATGTTCGCTGGAAGAAACA
A 
ATAATCTCCCGCGTGTCCAT 197 
zMyca GAACGGCATTCGTTAAACA
CAA 
TGGGCAGCAGTTCGAATTT 202 
zPim1 AATTCAACACATTTGCTCA
CATT 
TTTTGCAACATGCTTGATGG 191 
zSocs1a ATGGTGGCGCACAGTTCAG
T 
TGCATAGTTGAACGGCTTGA 153 
zSocs2 ATGACCTGTCACTCATCCG
AC 
GGCTTCATTGGCTGTCAGGC 162 
zSocs4 ATGTCTGAGAGGAAGACC
AAAAACT 
AGATCGAGCAGTCTGTTCGT 168 
zSocs9 CCACTGCCTCGTTCCTGAT
T 
CGAGAACAGGTAATCCTCCT 151 
zSurv1 TGGATCTTGCAAGTGATGA
TCA 
TTCCCATCCTTCCAGCTCTT 200 
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zSurv2 AAGACTTCAGACTTTTTCC
GAG 
GTGAAGAAAGGCACAGTTG
G 
214 
zTimp2 ATGAAGAGCGTCAGGAGC
TGTA 
GCTTGATCGGGTTCCCATAA 199 
zTgfb1a GTTGGTTTGCTTGGTGCTG
A 
ATCTTCTGTCCGTCGTCGTC 186 
zXiap ATGGCACACTCAACTCATA
ATGG 
GGCACTGCAGCTGAAACATT 192 
zIFNg ATGGATTCCTGCCTCAAAA
TG 
TCCAACCCAATCCTTTGCAA 171 
zNOS2 ATGGGAAGACAAGCACAA
ACCA 
GCCGCTTTGTGATGAAGTGA 158 
zIL8 ATGACCAGCAAAATCATTT
CAGTGTG 
AAATCTTTACAGTGTGGGCT
TG 
188 
zP53 TAT TCA GCC CCC AGG 
TGG TG 
GGA TAG TCG CTT GTC TCC 
GG 
162 
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5. Discussion 
In the present study, hIL6 gene was introduced into zebrafish and investigated that 
aberrant expression of the hIL6 has caused hepatocellular carcinogenesis. Although 
zebrafish has been used as an animal model system in the study of various human 
diseases, none of study expressing a human gene in the system to show its direct 
function has been reported. IL6 is a well known cytokine playing a crucial role in liver 
regeneration and also hepatic tumorigenesis depending on its expression condition.3-5, 9 
This pleiotrophic cytokine acts through signal transduction pathways.6-8 Among the 
pathways, STAT3 plays very important roles in inflammation and tumorigenesis of 
liver. STAT3 which belongs to the STAT protein family consisting of seven member is 
especially known to be a key element in tumor initiation and progression.25-26 Normal 
activation of STAT3 by phosphorylation in response to IL6 leads to turn on 
transcription of many downstream genes involved in development, while abnormal 
persistent activation of the element contributes to tumorigenesis and chronic 
inflammation, suggesting that STAT3 has dual role. Thus, our study focuses on 
inflammatory response and tumorigenesis by IL6/STAT3 signal using zebrafish model.  
To do this, different transgenic zebrafish lines containing sustained expression of hIL6 
gene which targets specifically to liver were generated (Fig. 1). Binary expression 
system using Gal4-UAS has provided a stable expression of the gene in all transgenic 
zebrafish and immunohistochemical experiments have well confirmed induction of 
chronic inflammatory change of the liver (Fig. 2,3). To determine the developmental 
progression of inflammation, the phenotype at different developmental stages of the 
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transgenic zebrafish was characterized. In our observation, massive infiltration of 
inflammatory cells was noted at 1 month of age in hepatic sinusoids and intrahepatic 
vessels in all transgenic zebrafishes expressing hIL6 gene (Fig. 2). At 2 months old of 
the hIL6-expressing transgenic zebrafish, dysplastic foci with various precancerous 
lesions began to appear in the liver (Fig. 4). The lesions included an appearance of 
clear cell bodies, eosinophilic and also basophilic cell bodies (Fig. 4). The results 
suggest that the persistent expression of hIL6 causes inflammation and tumorigenesis 
in zebrafish liver.   
Further investigation of the tumorigenesis was done by molecular and 
immunochemical analyses (Fig. 5-7). Since IL6 plays roles in liver regeneration and 
tumorigenesis by regulating intracellular signal transduction, an advantage of 
determining differential expression of the downstream genes involved in the signal 
transduction pathways was taken to show that the hepatocellular tumorigenesis is 
caused by the action of the chronic expression of hIL6 in the transgenic zebrafish. The 
RT-PCR experiment with hIL6 primer clearly showed the over-expression of hIL6 
gene in the transgenic zebrafish while the gene was not detected in non-transgenic 
zebrafish (Fig. 5b) and a consistency of this result was confirmed by a western blot 
analysis (Fig. 5c). The result suggests that a stable sustained expression of the hIL6 
transgene was successfully achieved in the zebrafish model system. Since the cytokine 
IL6 has a role in enhancing cellular proliferation and hindering apoptosis by 
downregulating different pathways during inflammation and tumorigenesis, qRT-PCR 
experiment against few selected genes that might be involved in the pathways of PI3K-
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Akt, Jak/Stat3, and Ras-Raf-Mapk was done. These three pathways are known to be 
activated upon response to IL6 binding to its membrane receptor, gp130, and control an 
array of dwonstream molecules involved in cell survival and proliferation.13 From the 
qRT-PCR result, their differential expression pattern into three categories, 
inflammation, survival, and proliferation was summarized (Fig. 5a). The results 
revealed that many of the genes are up-regulated. Among these, up-regulation of c-myc 
and Survivin genes are prominently noted. These two genes are known to play 
important roles in various carcinogenesis. The c-myc is known as a critical regulator of 
cell growth and upon stimulation of the IL6 receptor, the gene expression is rapidly 
induced by increasing STAT3.33 Furthermore, a very recent report has revealed that c-
myc expression is dependent on IL6 stimulation to up-regulate rRNA transcription  and 
the enhanced rRNA transcription stimulates MDM2-mediated proteasomal degradation 
of p53.36 This result suggests that IL6 also downregulates p53 expression leading to 
chronic inflammation and tumorigenesis. Survivin is a member of the inhibitors of 
apoptosis protein family that directly inhibits caspase-3 and caspase-7 activity and its 
over-expression has been reported in various cancer.34-35 Pim1, a serine-threonine 
kinase, is also known to suppress apoptosis and promote cell cycle progression.32 
Taken together, our qRT-PCR results suggested that the intracellular signaling 
activated by hIL6 enhances cell proliferation and reducing apoptosis inducing the liver 
inflammation and tumorigenesis in the zebrafish.   
 This is the first study reporting persistent expression of human IL6 in the liver 
induces chronic inflammation, dysplasia, and overt hepatocellular carcinoma in 
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transgenic zebrafish. Under normal circumstance, inflammation-associated expression 
of IL6 might have protective role of preventing hepatocyte death. Inappropriate or 
uncontrolled expression, however, can be detrimental to the liver causing accentuation 
of inflammatory process, cell damage and death, and eventually generation of 
dysplastic foci and hepatocellular carcinoma. Although the immunohistochemical 
analysis suggested that activation of Jak/Stat3 pathway played an important role in 
IL6-induced carcinogenesis in the zebrafish liver (Fig. 7), further investigation is 
necessary to demonstate its mechanism. For this reason, currently, inhibition analysis 
of the IL6 pathway responsible for the hepatocellular carcinogenesis (i.e., Jak/Stat3 
pathway) is undergoing. The analysis will take us further insight into revealing the 
mechanism of chronic inflammation caused by IL6.  
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Chapter 3.  Platform for intestine - specific expression of 
transgenes.  
 
1. Abstract   
In an effort to completion of zebrafish model platform of gastrointestinal 
expression, transgenic zebrafish has been established by using Cre-Loxp system 
(Tg(IFABP-CreERT2pA-Cmcl2-mcherry)).   In this system, tamoxifen-dependent 
transcription factor CreERT2 was expressed under the control of the regulatory 
element of zebrafish intestinal fatty acid binding protein (IFABP) gene. Transgene 
CreERT2 expression was confirmed by ISH for Cre in 4 dpf embryos.  
This platform line will be crossed with transgenic zebrafish in which transgene 
is expressed by recombinational excision of Loxp-stop-Loxp sequence by 
CreERT2 such as (Tg(UBB-Loxp-mCherry-Loxp-GFPKrasG12D). This strategy is 
used to induce expression of the transgene spcifically to intestinal organ and the 
established platform will be a valuable model for the study of human intestinal 
diseases. 
 
Key words: Transgenic zebrafish, IFABP, DCLK1a, Cre-loxp-Cre system. 
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2. Introduction  
Zebrafish (Danio rerio) has been used as an animal model system for 
developmental biology since 1980 and the system is now used to define the mechanism 
of tumorigenesis in recent years.[1,2] Zebrafish is about 3-4cm long when the fish is 
fully grown up at 10 weeks of generation cycle and contains 25 chromosomes. The fish 
interestingly conserves most of the genes found in human despite its diversity occurred 
3 billion years ago.  
Study in developmental biology, genetics, and tumorigenesis with zebrafish model 
system has different advantages; cost effectiveness, genomic similarity to human, huge 
production of progeny, and a short period of reproduction with 48 hours.[3,4] Also, the 
embryo can be easily detected under a fluorescence microscope when appropriate 
fluorescence biomarkers are used, allowing organ dependent expression of transgenes. 
[5] Since zebrafish undergoes with in vitro fertilization, researcher can easily 
manipulate transgenes for gain-of-function and knock-out purposes. For these, the 
animal system has been applied to investigate molecular and cellular mechanism of 
tumorigenesis since 2000.[6-11] 
Using BAC or plasmid transgene constructs, F0 founder fishes can be cultivated and 
reproduced for F1 progeny containing the transgene expression. In our organ specific 
expression study of the genes involved in intestinal tumorigenesis, ptf1a and elastase2 
is used for pancreas expression and the same as true for LFABP (Liver fatty acid 
binding protein) and IFABP (intestinal fatty acid binding protein) [12-14] for liver and 
intestine, respectively. DCLK1a gene can also be used to drive transgene expression in 
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the progenitor compartment of intestine.[15-20] For transgene expression analysis, 
Gal4-UAS system and/or LoxP-CreERT system are effectively used. In the system, 
Gal4 or CreERT contributes to organ specific expression from the transgene constructs 
under UAS or Loxp-stop-Loxp. Cre LoxP system allows temporal and spatial 
expression of the transgenes at desired developmental stages of the zebrafish. This 
strategy can be achieved by treating Tamoxifen which binds to Cre Recombinase 
(CreERT2), cutting Loxp-stop-Loxp sequence and inducing recombination of the 
transgenes.  Cre/loxP system overcomes this problem because the system can control 
the expression of particular genes in specific tissues and stages during development. To 
make this system working, targeted gene under a tissue-specific and stage-specific 
promoter has flanked by loxP sites. The loxP sites are then recognized by Tamoxifen-
dependent Cre recombinase, excising the gene at specific stages during development. 
Another strategy can be done to facilitate transgenic efficiency by using Tol2 which is 
recognized by T3 transposase. Introducing transgene constructs with transposase 
mRNA into fertilized eggs of zebrafish causes transpostion of the gene into zebrafish 
chromosome. [21-23] 
Gastrointestinal tract is an important system in which food is digested from 
esophagus to intestine for nutritional absorption and storage. Different cancers, 
however, occurred in the gastrointestinal tracts such as esophagus cancer, stomach 
cancer, colorectal cancer, liver cancer, pancreas cancer, and biliary tract cancer take 42% 
of total cancers occurred in Korea. Therefore, purpose of the present study is to 
develop zebrafish model system which demonstrates human cancer disease [24,25] 
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3. Materials and Methods 
1. Transgene constructs and transgenesis.  
This present experiment involves Loxp-Cre system for induced expression of 
transgene. To do this, first, CreERT2 gene was PCR-amplified and cloned into 
Mlu1/Nhe1 site of pUAS-GFPpA-Cmcl2-mCherry to generate pUAS-
CreERT2pA-Cmcl2-mCherry. Then, for intestine specific expression of transgene, 
upstream 3.0kb regulatory sequence of zIFABP (IFABP2) gene was PCR 
amplified from BAC DNA (CH73-34B5) and inserted into Apa1/Mlu1 site to 
generate the final transgene construct, pIFABP-CreERT2pA-Cmcl2-mcherry (table 
1). All constructs used in this study were sequenced and verified using the 
appropriate primers listed in Table 1. Each injection mixture was prepared by 
reconstituting Tol2-transposase mRNA (20 ng/ul) and transgene construct (20 
ng/ul) in Danieu’s buffer mixed with 0.03% phenol red. AB embryos at single-cell 
stage were transferred to a molded agarose dish and 4 pL of the injection mixture 
of pIFABP-CreERT2pA-Cmcl2-mcherry was introduced by yolk injection using a 
MMPI-2 microinjector. F0 founder embryos showing robust cardiac mCherry 
expression were selected under a fluorescence microscope (Olympus, Japan). The 
embryos were then raised and bred to give a birth to F1 embryos showing non-
mosaic mCherry expression in the heart. Intestinal expression of CreERT2 was 
confirmed by ISH for Cre using 4 dpf-old transgenic embryos. Transgenic 
embryos, Tg(UBB-Loxp-mCherry-Loxp-GFPKrasG12D) were kind gift from Park 
of Johns Hopkins Medical Institution. By crossing Tg(IFABP-CreERT2pA-
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Cmcl2-mcherry) and Tg (UBB-Loxp-mCherry-Loxp-GFPKrasG12D), transgenic 
zebrafish in which dominant-active Kras gene is expressed by tamoxifen induction 
was established. All transgenes were transmitted in normal Mendelian ratio. 
2. Animal stocks and embryo care.  
All zebrafish were raised in a standardized aquaria system (Genomic-Design 
Co., Daejeon, Korea) according to standard protocols at 28°C on a 14- to 10-hour 
light and dark cycle. Embryos to be processed for whole mount analyses were 
placed in an E3 media with 0.003% phenylthiourea at 24 hpf to inhibit 
pigmentation. This experiment strictly followed the Guidelines for the Welfare and 
Use of Animals in Cancer Research. 
3. In situ hybridization (ISH). 
PCR amplification was done by using One-Step RT-PCR kit (Invitrogen) and 
amplified particial conding sequence was purified by gel extraction kit (Qiagen) 
and used for probe synthesis. (CreER sense: 5’- 
ATAACGCGTACCATGTCCAATTTACTGACCGTA-3’, antisense; 5’- 
CTAATACGACTCACTATAGGGATTGCCCCTGTTTCACTATC’).  The 
amplified sequence was inserted into PCRII vector. Then, PCRII plasmid with 
coding sequence was linearized and antisense riboprobe was generated by in vitro 
transcription using digoxigenin labelling mixture (Roche Diagnostics GmbH, 
Mannheim, Germany). Control sense probes were run in parallel for all 
experiments. Experiments were performed using either whole embryos or 4um 
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section slides. Specimens were fixed in 4% paraformaldehyde (PFA) on rotate for 
overnight at 4 °C, dehydrated in a graded methanol series and stored in 100% 
MeOH. Samples were reconstituted in PBS with 0.1% Tween20 (PBST) and 
treated with 5mg/ml Proteinase K for 20 min 20 min at room temperature. 
Rehydrated samples were prehybridized with 50% formamide, 5X SSC, 50ug/mL 
heparin, 9.2 mM citric acid, 0.1% Tween-20, and 500ug/mL Torula yeast RNA 
(Sigma, St. Louis, MO) for 3 h at 65°C followed by overnight hybridization with 
DIG-labeled RNA. Post-hybridization washes were done at 68 °C at least 4 hours 
as follows  2 washes in  2×SSC 0.1% Tween-20 for 10 minutes, one wash in 
2×SSC 0.1% Tween-20 for 10 minutes followed by two washes in 0.2×SSC 0.1% 
Tween-20 for 30 minutes. All washing solutions were pre-warmed to 65°C. 
Subsequently, specimens were rinsed twice with PBST.  Tissue was incubated in 
Anti-DIG alkaline phosphatase antibody (Roche) in blocking overnight at 4 °C. 
Tissue was washed in PBST After extensive washing, samples are visualized by 
incubating with NBT/BCIP AP substrate solution (Roche Diagnostics GmbH)  in 
0.1 M Tris–HCl, pH 9.5, 0.1 M NaCl, 50 mM MgCl2, 0.1% Tween 20. Whole 
mount embryos were immersed in glycerol for better visualization. The sections 
were counterstained with neutral red and mounted with Histomount. 
5. Imaging  
Olympus MVX10 was used for whole mount embryo imaging.  
4. Results 
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1. Strategy of intestine-specific expression platform 
To achieve intestinal specific gene expression, CreERT2 gene has been put under  
IFABP promoter which is specifically expressed in intestine, establishing a Cre-lox-
Cre system of the IFABP-CreERT2 (GI tract) transgenic lines of zebrafish (Fig. 1). 
CMV-loxp-stop-loxp-K-RAS (G12V) construct has also been used and the oncogene, 
K-RAS, has been induced for selective expression (Fig.2A). Tamoxifen treatment was 
done at 1 month after birth of zebrafish.  
 
2. Expression analysis of intestine-specific transgene 
For intestinal expression analysis, CreERT and molecular biomarker genes were 
used appropriately to tract their transgenic expressions in intestinal organs of zebrafish. 
The results revealed intestinal specific expression of CreERT in IFABP-CreERT 
transgenic lines. (Fig. 2) This established platform will be a useful experimental model 
system in demonstrating human gastrointestinal diseases.  
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Fig 1. Schematic illustration of Cre-loxp-Cre system. CreERT2 recombinase 
expressed under the control of IFABP or DCLK1a regulatory element excises Loxp-
stop-Loxp sequence under the presence of tamoxifen, which induces downstream gene 
in intestine-speficic manner. 
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Table 1. Primers used for the generation of transgene contructs. 
F-UAS-Seq was used for sequence verification of constructs. Underlined GCCACC sequence 
was inserted for  
Primers Sequence 
F1-CreER-Mlu1 5’-ATAACGCGTACCATGTCCAATTTACTGACCGTA-3’ 
R1-CreER-Nhe1 
5’-ATAGCTAGCTCAAGCTGTGGCAGGGAAAC-3’ 
F0-EGFP-Mlu1 
5’- ATAACGCGTATGGTGAGCAAGGGCGAGGAG-3’ 
R6-EGFP-Cla 
5’-ACTAATCGATTTACTTGTACAGCTCGTCCAT-3’ 
F1-zFABP2-u3k-Apa1 5’- ACTAGGGCCCACCTCCGTCTTGTGGTACAA-3’ 
R2-zFABP2-Mlu1 5’- ATAACGCGTCCCGTTGAAGGTCATGATGA-3’ 
F1-zDCLK1a-Apa 
5’- ACTAGGGCCCATTGAGACATGCCCCTGTCT -3’ 
R1-zDCLK1a-Mlu 
5’- ATAACGCGTTTCGTATTGCAGCATGTTGA-3’ 
 
 Underlines, restriction enzyme sequences 
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Fig 2. Targeted expression of transgenes in embryos. (A) Transgene construct for 
Cre-Loxp system. Spatio-temporally restricted expression of Gene, L: Loxp, IFABP: 
intestinal fatty acid binding protein, UBB: Ubiquitin B, DCLK1a: doublecortin-like 
kinase 1a, GFP-KrasG12D: dominant-active Kras as fusion gene (B) Transgenic 
embryos at 96 hpf. a. Inverted fluorescence image. b. Bright field image. c. Merged 
image. Red flurescence of moderate intensity at whole body and strong red at heart 
confirm the presence of both treansgenic construct.  d. ISH for Cre showing robust 
expression at intestine.  
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5. Discussion 
Gene expression analysis during embryonic development of animal model system 
requires specialized techniques especially when the transgene expression is toxic to the 
embryo because the embryo dies before development into aldut stage. For this reason, 
selecting an expression startegy of the transgene at particular developmenatal stage is 
very important.  Gal4-UAS system and/or LoxP-CreERT system can be an effective 
choice for this type of expression analysis. In the system, Gal4 or CreERT contributes 
to organ specific expression from the transgene constructs under UAS or Loxp-stop-
Loxp. Cre LoxP system allows temporal and spatial expression of the transgenes at 
desired developmental stages of the zebrafish becuase the transgene expression can be 
controlled by treating Tamoxifen which binds to Cre Recombinase (CreERT2), cutting 
Loxp-stop-Loxp sequence and inducing recombination of the transgenes.  
 Purpose of this study is to establish an expression platform that can be identified 
specifically in intestine. IFABP or DCLK1a is a useful regulatory element to make a 
transgene expression in intestinal organs. Thus, IFABP has been chosen to drive 
CreERT in differentiated intestinal cells. In this preliminary study, CreERT2 
expression was detected by ISH in zebrafish intestine, suggesting that the transgene is 
expressed at desired developmental stages.   
 Establishing an intestine specific expression platform is important for human 
gastrointestinal cancer study. Althogh the present study is preliminary and requires 
further confirmation, the study suggests that zebrafish is a very useful model system 
for the study of human cancer disease. 
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형질 전환 기법을 활용한 제브라피쉬 소화기질환 
모델의 개발과 응용 
연세대학교 대학원 
나노메디컬협동과정 
정인혜 
 
제브라피쉬(Danio rerio )는 1980년대 발생생물학 모델로 이용되기 시작하였
고, 2000년대부터 종양생물학 모델로 가치가 부각되었다. 3년생 열대담수어인 
제브라피쉬는 성어의 크기가 3-4cm이고 세대기간 10주이며 25쌍의 염색체를 
지니며, 진화상으로 3억년 전에 인류의 공통 조상에서 분리가 되었음에도 유전
자가 보존되어 있어 인간이 가지는 거의 모든 유전자를 보유하고 있다. 이 외에
도 제브라피쉬는 발생학, 유전학, 종양생물학 연구에 있어서 몇 가지 장점을 지
닌다. 첫째, 초기비용과 유지비용이 낮아 비용효과적이다. 둘째, 백서에는 미치
지 못하지만 초파리나 선형동물에 비하여 유전적으로 인간과 매우 유사하다. 
셋째, 다수의 수정란을 생산하기 때문에 저비용 고효율 연구가 가능하다. 넷째, 
배아가 투명하고 48시간의 짧은 발생기간을 가지기 때문에 실시간 관찰이 가
능하다. 기관 특이적으로 형광단백과 같은 생물표지자를 발현시키면 생체에서 
실시간으로 특정기관의 관찰이 가능하고 배아단계에서는 세포 수준의 추적이 
가능해서 발생생물학 연구에 매우 유용하다. 다섯째, 체외수정을 하기 때문에 
수정란의 난황으로 손쉽게 유전물질을 주입하여 유전자조작(gain-of-
function, knock-out)이 용이하다. 이러한 장점에 기인하여 1981년에 모델로 
수립된 이후 급속한 발전과 전파를 거쳐 발생생물학과 유전학 연구의 핵심적인 
모델의 하나로 정립되었다. 
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 2000년 이후 형질전환 제브라피쉬 혈액암 모델을 시작으로 다양한 제브라피
쉬 형질전환 암모델이 수립되기 시작하였으며 매년 수립되는 모델의 수가 증가
하고 있는 추세이다. 손쉽게 벤치 사이드에서 형질전환을 할 수 있다는 장점은 
유전자의 기관특이적 발현을 통한 종양유전자의 연구가 진행된 계기가 되었다.  
질병모델의 수립은 기관특이적 전환유전자의 발현을 이용하는 형질전환 기법
이 흔히 이용되고 있다. 형질전환은 원래의 세포에는 없는 DNA를 외부에서 투
여하여 세포의 유전 형질을 변환시키는 분자생물학적 기법을 말한다. 형질전환
에는 다양한 기법과 전략이 개발되어 있으나, 흔히 실험실에서 형질전환을 위
한 BAC 또는 plasmid를 조작하여 전환유전자 콘스트럭트를 제작한 다음 수정
란으로 미세주입하여 염색체로 삽입시키는 방법이 이용된다. 특정 기관의 질병
모델 개발을 위해서는 기관특이적인 유전자 발현을 유도하는 전략을 이용한다.  
소화기계는 식도, 위, 장 등 음식물의 이동 및 흡수 경로가 되는 위장관, 음식물
의 소화를 유발하는 소화액을 분비하는 췌장, 담도 및 각종 단백을 생산하고 영
양분을 저장하는 간을 포함하는 시스템이다. 소화기계에는 식도암, 위암, 대장
직장암, 간암, 췌장암, 담도암 등 다양한 암종이 발생하고 있고 국내에서 전체
암의 42%를 차지하고 있어 국가보건의 주요 이슈이기도 하다. 소화기계 질병 
모델의 체계적인 구축을 위해서는 이들 장기에 기관특이적으로 질병 관련 유전
자를 발현할 수 있는 플랫포옴의 개발이 필요하다. 연구자는 소화기계 기관별 
특이적인 전환유전자를 발현할 수 있는 모델 플랫포옴을 구축하고 형질전환주
를 수립하여 구축된 모델이 실제 인간의 질병을 모방할 수 있는지 규명하고자 
본 연구를 진행하였다. 
소화기계의 기관특이적 유전자 발현을 위하여 췌장은 ptf1a, 간은 Liver fatty 
acid binding protein (LFABP), 위장관은 intestinal fatty acid binding 
protein (IFABP) 조절인자를 이용하였다. 전환유전자의 발현은 Gal4-UAS 시
스템 또는 LoxP-CreERT 시스템을 이용하였다.  이는 전환유전자의 이소성 
발현을 최소화하기 위한 전략으로 Gal4 또는 CreERT가 고도로 기관특이적인 
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발현을 보이도록 구축한 형질전환주를 기반으로 하여, UAS 하방 또는 Loxp-
stop-Loxp 하방에 유전자를 클로닝하여 별개의 형질전환주를 수립한 뒤 교배
를 통하여 원하는 기관에 전환유전자가 발현되도록 하였다. Cre LoxP 시스템
은 시공간적 발현조절이 가능하여 목표 장기에서 발현되는 Cre 
Recombinase(CreERT2)와 원하는 시기에 외부에서 투여하는 Tamoxifen과 
결합한 뒤 loxP-stop-loxP 서열을 절단, 재조합하면 전환유전자가 발현되도
록 하였다.  또한 연구자는 형질전환의 효율을 높이기 위하여 삽입하고자 하는 
DNA 서열의 5’ 및 3’에 T3 transposase가 인식하는 Tol2 서열을 넣었다. 형
질전환을 위한 수정란내 미세주입시 transposase mRNA와 형질전환 콘스트
럭트 플라스미드를 함께 주입하면 transposase에 의하여 Tol2 서열 사이의 
DNA가 염색체로 강제 치환되기 때문에 형질전환의 효율을 극대화 할 수 있다. 
상기 시스템을 활용하여 연구자는 소화기관 선택적으로 종양유전자를 발현하
는 형질전환 제브라피쉬 모델 플랫포옴을 구축하고 유전자 발현에 의한 표현형
을 분자/세포 생물학 수준에 검증함으로써 제브라피쉬 모델 시스템의 유용성을 
확립하고자 하였다. ptf1a 유전자는 인간과 백서에서 망막, 소뇌, 췌장의 발생
에 핵심적인 기능을 하는 전사인자이다. 제브라피쉬에서도 마찬가지로 발생시 
망막, 후뇌, 외분비췌장에 발현된다. 차이점으로 인간과 백서에서는 내, 외분비 
췌장 모두의 발생에 필수적이지만 제브라피쉬에서는 외분비췌장의 발생에만 
관여하기 때문에 외분비췌장 특이적인 유전자발현을 유도하는데 적합한 유전
자이다. 분화전 전구세포에서 발현되는 ptf1a 유전자를 포함하는 BAC DNA를 
재조합방식으로 조작하여 ptf1a-Gal4 형질전환주를 구축하였고, UAS-Shh 
및 UAS-Ihh 형질전환주를 구축하여 고배함으로써 ptf1a 영역에 hedgehog 리
간드가 발현되는 이중 형질전환주를 구축하였다.  
형질전환주의 표현형을 분석하여 hedgehog 신호의 활성화는 paracrine 기전
을 통하여 췌장의 섬유화가 유발됨을 제브라피쉬 형질전환주를 통하여 in vivo
에서 규명하였다. Hedgehog 경로의 활성화에 의해 췌장 섬유화가 발생함을 
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보여주며 이는 인간의 만성췌장염 및 췌장암에서 나타나는 췌장 섬유화와 조직
학적 및 분자생물학적으로 매우 유사함을 확인하였다. 
본 연구자는 제브라피쉬에서 발생 단계부터 간특이적으로 유전자가 발현되는 
형질전환 플랫포옴을 구축하기 위하여 liver fatty acid binding protein 
(LFABP)를 선택하여 5‘ upstream 2.9kb (조절서열)를 클로닝하였다.  
LFABP 조절서열의 특이성을 분석하기 위하여 LFABP-GFP 콘스트럭트를 제
작하여 형질전환 제브라피쉬를 수립하여 확인하였다. 간의 만성염증을 촉진시
켜 간암 발생에 중요한 역할을 하는 IL-6 유전자를 선정하였고, UAS-hIL6-
CG 형질전환주를 별도로 수립하여 LFABP-Gal4 / UAS-RFP 전환주와 교배
함으로써 간 특이적으로 hIL6를 발현하는 triple 형질전환주를(LFABP-Gal4 / 
UAS-RFP / UAS-hIL6-CG) 수립하였다. hIL6 발현은 간에 만성적인 염증세
포의 침윤과 이에 따른 간세포의 손상과 재생을 유발하였고, 생후 3개월부터 
다양한 이형성을 유발하였다. 6개월에는 만성염증성 변화와 아울러 AFP 양성
인 간세포암이 발생하였다. 
분자수준에서의 분석상 hIL6의 발현은 PI3K/Akt, Jak/Stat3, Raf/MAPK 신호 
경로를 활성화 시킴이 확인되었다. 면역염색상 대부분의 간세포와, 이형성세포, 
간암세포에 활성화된 pStat3가 강양성을 보여 만성염증에 따른 간암 발생과정
에서 Jak/Stat3 신호경로가 주요한 역할을 함을 시사하였다. 반면에 pPI3K는 
간세포보다는 주로 침윤된 염증세포에서 발현을 보였다. 이상의 결과는 강력한 
염증유발 유전자인 hIL6의 간특이적 발현에 의하여 발생하는 간세포암화 과정
에서 Jak/Stat3가 주도적인 역할을 하고 있음을 의미한다.  
위장관 발현주는 Gal4자체의 독성으로 인하여 생존이 불가하여 IFABP – 
CreERT 형질전환주 수립을 통하여 시공간적 발현 조절이 가능한 형질 전환 전
략으로 전환하였다. Cre-lox-Cre 시스템은 recombination을 통하여 유전자 
재조합을 유발하면 지속적으로 유전자발현이 유도된다. 제브라피쉬 IFABP 유
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전자의 5’ 조절서열 3kb를 성공적으로 클로닝하였고, 위장관 특이적 Cre-lox-
Cre 시스템을 구축하기 위하여 IFABP-CreERT2-CmC 형질전환주를 수립하
였으며, CreERT2의 위장관 특이적 발현을 ISH을 통하여 확인하였다. 플랫포
옴이 되는 IFABP-CreERT2주는 CMV-loxp-stop-loxp-transgene 주와 교
배하여 Cre-LoxP 시스템에 의하여 발현이 유도되는 위장관모델주를 수립하
는데 이용할 예정이다.  
이상의 결과로 연구자는 제브라피쉬 소화관 발현 모델 플랫포옴을 성공적으로 
구축하였다. 췌장특이적 발현은 Ptf1a, 간특이적 발현은 LFABP, 장관특이적
발현은 IFABP 유전자의 조절염기서열에 의해 각각 유도되는 시스템이며, 
Gal4-UAS 또는 Cre-LoxP 시스템에 의해 발현이 조절된다. 수립된 플랫포옴
주를 바탕으로 별도로 수립하는 UAS-유전자, 또는 LSL-유전자 형질전환주와 
교배함으로써 binary expression 시스템을 손쉽게 완성할 수 있다. 다양한 종
양 발생관련 유전자를 이용하여 단기간 내에 원하는 장기에 유전자를 발현하는 
형질전환주를 수립할 수 있으며 이러한 시스템은 향후 제브라피쉬가 종양생물
학 연구를 위한 모델로서의 가치가 확장되는데 일조할 것으로 판단한다. 
 
핵심이 되는 말:  형질전환, 제브라피쉬, 췌장, 간, 장관, Ptf1a, LFABP, IFABP, 
Hedgehog, Interleukin-6, 섬유화, 간세포암. 
 
